<b><i><font style="font-family: 'Times New Roman', Times">Esprit
    Acquisition</font></i></b><div style="margin-top: 6pt; font-size: 1pt"></div><div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    On October16, 2007, we completed the acquisition of
    Esprit, a pharmaceutical company based in the United States with
    expertise in the genitourinary market, for an aggregate purchase
    price of approximately $370.7million, net of cash
    acquired. The acquisition was funded from our cash and
    equivalents balances. See Note2, Acquisitions,
    in the notes to our consolidated financial statements listed
    under Item15 of PartIV of this report,
    Exhibits and Financial Statement Schedules.
</div><div style="margin-top: 6pt; font-size: 1pt"></div><div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    We believe the fair values assigned to the Esprit assets
    acquired and liabilities assumed were based on reasonable
    assumptions. The following table summarizes the estimated fair
    values of net assets acquired:
</div><div style="margin-top: 6pt; font-size: 1pt"></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF" width="100%">
<!-- Table Width Row BEGIN -->
<tr style="font-size: 1pt" valign="bottom">
<td width="89%"></td> <!-- colindex=01 type=maindata -->
<td width="2%"></td> <!-- colindex=02 type=gutter -->
<td align="right" width="4%"></td> <!-- colindex=02 type=lead -->
<td align="right" width="1%"></td> <!-- colindex=02 type=body -->
<td align="left" width="4%"></td> <!-- colindex=02 type=hang1 -->
</tr>
<!-- Table Width Row END -->
<tr align="center" style="font-size: 8pt" valign="bottom">
<td align="center" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" valign="bottom">
<b>(in millions)</b>
</td>
</tr>
<tr style="line-height: 3pt; font-size: 1pt">
<td>
</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Current assets
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    35.8
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Identifiable intangible assets
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    358.0
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Goodwill
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    122.6
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Other non-current assets
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    8.6
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Accounts payable and accrued liabilities
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    (24.2
</td>
<td align="left" nowrap="" valign="bottom">
    )
</td>
</tr>
<tr valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Deferred tax liabilities
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    (128.9
</td>
<td align="left" nowrap="" valign="bottom">
    )
</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Other non-current liabilities
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    (1.2
</td>
<td align="left" nowrap="" valign="bottom">
    )
</td>
</tr>
<tr style="font-size: 1pt" valign="bottom">
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 1px solid #000000">

</td>
<td>

</td>
</tr>
<tr valign="bottom">
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    370.7
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr style="font-size: 1pt" valign="bottom">
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 3px double #000000">

</td>
<td>

</td>
</tr>
</table><tr style="font-size: 1pt" valign="bottom">
<td width="89%"></td> <!-- colindex=01 type=maindata -->
<td width="2%"></td> <!-- colindex=02 type=gutter -->
<td align="right" width="4%"></td> <!-- colindex=02 type=lead -->
<td align="right" width="1%"></td> <!-- colindex=02 type=body -->
<td align="left" width="4%"></td> <!-- colindex=02 type=hang1 -->
</tr><td width="89%"></td><tr align="center" style="font-size: 8pt" valign="bottom">
<td align="center" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" valign="bottom">
<b>(in millions)</b>
</td>
</tr><td align="center" nowrap="" valign="bottom">

</td><td align="center" colspan="3" nowrap="" valign="bottom">
<b>(in millions)</b>
</td><b>(in millions)</b><tr style="line-height: 3pt; font-size: 1pt">
<td>
</td>
</tr><td>
</td><tr style="background: #CCEEFF" valign="bottom">
<td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Current assets
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    35.8
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr><td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Current assets
</div>
</td><div style="text-indent: -10pt; margin-left: 10pt">
    Current assets
</div><td>

</td><td align="right" nowrap="" valign="bottom">
    $
</td><td align="right" nowrap="" valign="bottom">
    35.8
</td><td align="left" nowrap="" valign="bottom">

</td><tr valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Identifiable intangible assets
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    358.0
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr><td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Identifiable intangible assets
</div>
</td><div style="text-indent: -10pt; margin-left: 10pt">
    Identifiable intangible assets
</div><td>

</td><td align="right" nowrap="" valign="bottom">
    358.0
</td><td align="left" nowrap="" valign="bottom">

</td><tr style="background: #CCEEFF" valign="bottom">
<td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Goodwill
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    122.6
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr><td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Goodwill
</div>
</td><div style="text-indent: -10pt; margin-left: 10pt">
    Goodwill
</div><td>

</td><td align="right" nowrap="" valign="bottom">
    122.6
</td><td align="left" nowrap="" valign="bottom">

</td><tr valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Other non-current assets
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    8.6
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr><td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Other non-current assets
</div>
</td><div style="text-indent: -10pt; margin-left: 10pt">
    Other non-current assets
</div><td>

</td><td align="right" nowrap="" valign="bottom">
    8.6
</td><td align="left" nowrap="" valign="bottom">

</td><tr style="background: #CCEEFF" valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Accounts payable and accrued liabilities
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    (24.2
</td>
<td align="left" nowrap="" valign="bottom">
    )
</td>
</tr><td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Accounts payable and accrued liabilities
</div>
</td><div style="text-indent: -10pt; margin-left: 10pt">
    Accounts payable and accrued liabilities
</div><td>

</td><td align="right" nowrap="" valign="bottom">
    (24.2
</td><td align="left" nowrap="" valign="bottom">
    )
</td><tr valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Deferred tax liabilities
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    (128.9
</td>
<td align="left" nowrap="" valign="bottom">
    )
</td>
</tr><td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Deferred tax liabilities
</div>
</td><div style="text-indent: -10pt; margin-left: 10pt">
    Deferred tax liabilities
</div><td>

</td><td align="right" nowrap="" valign="bottom">
    (128.9
</td><td align="left" nowrap="" valign="bottom">
    )
</td><tr style="background: #CCEEFF" valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Other non-current liabilities
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    (1.2
</td>
<td align="left" nowrap="" valign="bottom">
    )
</td>
</tr><td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Other non-current liabilities
</div>
</td><div style="text-indent: -10pt; margin-left: 10pt">
    Other non-current liabilities
</div><td>

</td><td align="right" nowrap="" valign="bottom">
    (1.2
</td><td align="left" nowrap="" valign="bottom">
    )
</td><tr style="font-size: 1pt" valign="bottom">
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 1px solid #000000">

</td>
<td>

</td>
</tr><td>

</td><tr valign="bottom">
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    370.7
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr><td align="left" nowrap="" valign="bottom">

</td><td align="right" nowrap="" valign="bottom">
    $
</td><td align="right" nowrap="" valign="bottom">
    370.7
</td><td align="left" nowrap="" valign="bottom">

</td><tr style="font-size: 1pt" valign="bottom">
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 3px double #000000">

</td>
<td>

</td>
</tr><td>

</td><div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
</div><div style="margin-top: 6pt; font-size: 1pt"></div><div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Our fair value estimates for the Esprit purchase price
    allocation may change during the allowable allocation period,
    which is up to one year from the acquisition date, if additional
    information becomes available.
</div><div style="margin-top: 12pt; font-size: 1pt"></div><div align="left" style="margin-left: 4%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">
<b><i><font style="font-family: 'Times New Roman', Times">EndoArt
    Acquisition</font></i></b>
</div><b><i><font style="font-family: 'Times New Roman', Times">EndoArt
    Acquisition</font></i></b><div style="margin-top: 6pt; font-size: 1pt"></div><div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    On February22, 2007, we completed the acquisition of
    EndoArt, a provider of telemetrically-controlled (or
    remote-controlled) implants used in the treatment of morbid
    obesity and other conditions. Under the terms of the purchase
    agreement, we acquired all of the outstanding capital stock of
    EndoArt for an aggregate purchase price of approximately
    $97.1million, net of cash acquired. The acquisition
    consideration was all cash, funded from our cash and equivalents
    balances. See Note2, Acquisitions, in the
    notes to our consolidated financial statements listed under
    Item15 of PartIV of this report, Exhibits and
    Financial Statement Schedules.
</div><div style="margin-top: 6pt; font-size: 1pt"></div><div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    We believe the fair values assigned to the EndoArt assets
    acquired and liabilities assumed were based on reasonable
    assumptions. The following table summarizes the estimated fair
    values of net assets acquired:
</div><div style="margin-top: 6pt; font-size: 1pt"></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF" width="100%">
<!-- Table Width Row BEGIN -->
<tr style="font-size: 1pt" valign="bottom">
<td width="89%"></td> <!-- colindex=01 type=maindata -->
<td width="2%"></td> <!-- colindex=02 type=gutter -->
<td align="right" width="4%"></td> <!-- colindex=02 type=lead -->
<td align="right" width="1%"></td> <!-- colindex=02 type=body -->
<td align="left" width="4%"></td> <!-- colindex=02 type=hang1 -->
</tr>
<!-- Table Width Row END -->
<tr align="center" style="font-size: 8pt" valign="bottom">
<td align="center" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" valign="bottom">
<b>(in millions)</b>
</td>
</tr>
<tr style="line-height: 3pt; font-size: 1pt">
<td>
</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Current assets
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    0.8
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Property, plant and equipment
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    0.7
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Identifiable intangible assets
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    17.6
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    In-process research and development
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    72.0
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Goodwill
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    7.4
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Accounts payable and accrued liabilities
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    (0.8
</td>
<td align="left" nowrap="" valign="bottom">
    )
</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Deferred tax liabilities
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    (0.6
</td>
<td align="left" nowrap="" valign="bottom">
    )
</td>
</tr>
<tr style="font-size: 1pt" valign="bottom">
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 1px solid #000000">

</td>
<td>

</td>
</tr>
<tr valign="bottom">
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    97.1
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr style="font-size: 1pt" valign="bottom">
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 3px double #000000">

</td>
<td>

</td>
</tr>
</table><tr style="font-size: 1pt" valign="bottom">
<td width="89%"></td> <!-- colindex=01 type=maindata -->
<td width="2%"></td> <!-- colindex=02 type=gutter -->
<td align="right" width="4%"></td> <!-- colindex=02 type=lead -->
<td align="right" width="1%"></td> <!-- colindex=02 type=body -->
<td align="left" width="4%"></td> <!-- colindex=02 type=hang1 -->
</tr><td width="89%"></td><tr align="center" style="font-size: 8pt" valign="bottom">
<td align="center" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" valign="bottom">
<b>(in millions)</b>
</td>
</tr><td align="center" nowrap="" valign="bottom">

</td><td align="center" colspan="3" nowrap="" valign="bottom">
<b>(in millions)</b>
</td><b>(in millions)</b><tr style="line-height: 3pt; font-size: 1pt">
<td>
</td>
</tr><td>
</td><tr style="background: #CCEEFF" valign="bottom">
<td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Current assets
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    0.8
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr><td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Current assets
</div>
</td><div style="text-indent: -10pt; margin-left: 10pt">
    Current assets
</div><td>

</td><td align="right" nowrap="" valign="bottom">
    $
</td><td align="right" nowrap="" valign="bottom">
    0.8
</td><td align="left" nowrap="" valign="bottom">

</td><tr valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Property, plant and equipment
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    0.7
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr><td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Property, plant and equipment
</div>
</td><div style="text-indent: -10pt; margin-left: 10pt">
    Property, plant and equipment
</div><td>

</td><td align="right" nowrap="" valign="bottom">
    0.7
</td><td align="left" nowrap="" valign="bottom">

</td><tr style="background: #CCEEFF" valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Identifiable intangible assets
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    17.6
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr><td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Identifiable intangible assets
</div>
</td><div style="text-indent: -10pt; margin-left: 10pt">
    Identifiable intangible assets
</div><td>

</td><td align="right" nowrap="" valign="bottom">
    17.6
</td><td align="left" nowrap="" valign="bottom">

</td><tr valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    In-process research and development
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    72.0
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr><td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    In-process research and development
</div>
</td><div style="text-indent: -10pt; margin-left: 10pt">
    In-process research and development
</div><td>

</td><td align="right" nowrap="" valign="bottom">
    72.0
</td><td align="left" nowrap="" valign="bottom">

</td><tr style="background: #CCEEFF" valign="bottom">
<td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Goodwill
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    7.4
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr><td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Goodwill
</div>
</td><div style="text-indent: -10pt; margin-left: 10pt">
    Goodwill
</div><td>

</td><td align="right" nowrap="" valign="bottom">
    7.4
</td><td align="left" nowrap="" valign="bottom">

</td><tr valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Accounts payable and accrued liabilities
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    (0.8
</td>
<td align="left" nowrap="" valign="bottom">
    )
</td>
</tr><td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Accounts payable and accrued liabilities
</div>
</td><div style="text-indent: -10pt; margin-left: 10pt">
    Accounts payable and accrued liabilities
</div><td>

</td><td align="right" nowrap="" valign="bottom">
    (0.8
</td><td align="left" nowrap="" valign="bottom">
    )
</td><tr style="background: #CCEEFF" valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Deferred tax liabilities
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    (0.6
</td>
<td align="left" nowrap="" valign="bottom">
    )
</td>
</tr><td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Deferred tax liabilities
</div>
</td><div style="text-indent: -10pt; margin-left: 10pt">
    Deferred tax liabilities
</div><td>

</td><td align="right" nowrap="" valign="bottom">
    (0.6
</td><td align="left" nowrap="" valign="bottom">
    )
</td><tr style="font-size: 1pt" valign="bottom">
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 1px solid #000000">

</td>
<td>

</td>
</tr><td>

</td><tr valign="bottom">
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    97.1
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr><td align="left" nowrap="" valign="bottom">

</td><td align="right" nowrap="" valign="bottom">
    $
</td><td align="right" nowrap="" valign="bottom">
    97.1
</td><td align="left" nowrap="" valign="bottom">

</td><tr style="font-size: 1pt" valign="bottom">
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 3px double #000000">

</td>
<td>

</td>
</tr><td>

</td><div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
</div><div style="margin-top: 12pt; font-size: 1pt"></div><div align="left" style="margin-left: 4%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">
<b><i><font style="font-family: 'Times New Roman', Times">Cornal
    Acquisition</font></i></b>
</div><b><i><font style="font-family: 'Times New Roman', Times">Cornal
    Acquisition</font></i></b><div style="margin-top: 6pt; font-size: 1pt"></div><div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    On January2, 2007, we purchased all of the outstanding
    common stock of Cornal, a privately held healthcare
    company that develops, manufactures and markets dermal fillers,
    viscoelastics and a range of ophthalmic surgical device
    products, for an aggregate purchase price of approximately
    $209.2million, net of cash acquired. The acquisition was
    funded from our cash and equivalents balances and our committed
    long-term credit facility. See Note2,
    Acquisitions, in the notes to our consolidated
    financial statements listed under Item15 of PartIV
    of this report, Exhibits and Financial Statement
    Schedules.
</div><p align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<br/>
    72
</p><br/><p>
</p><h5 align="left" style="page-break-before:always"><a href="#tocpage">Table of Contents</a></h5><p>
</p><div style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->
<div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    We believe the fair values assigned to the Cornal assets
    acquired and liabilities assumed were based upon reasonable
    assumptions. The following table summarizes the estimated fair
    values of the net assets acquired:
</div>
<div style="margin-top: 6pt; font-size: 1pt"></div>
<table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF" width="100%">
<!-- Table Width Row BEGIN -->
<tr style="font-size: 1pt" valign="bottom">
<td width="89%"></td> <!-- colindex=01 type=maindata -->
<td width="2%"></td> <!-- colindex=02 type=gutter -->
<td align="right" width="4%"></td> <!-- colindex=02 type=lead -->
<td align="right" width="1%"></td> <!-- colindex=02 type=body -->
<td align="left" width="4%"></td> <!-- colindex=02 type=hang1 -->
</tr>
<!-- Table Width Row END -->
<tr align="center" style="font-size: 8pt" valign="bottom">
<td align="center" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" valign="bottom">
<b>(in millions)</b>
</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Current assets
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    38.9
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Property, plant and equipment
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    19.5
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Identifiable intangible assets
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    115.7
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr valign="bottom">
<td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Goodwill
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    109.2
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Other non-current assets
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    1.5
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Accounts payable and accrued liabilities
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    (16.4
</td>
<td align="left" nowrap="" valign="bottom">
    )
</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Current portion of long-term debt
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    (11.6
</td>
<td align="left" nowrap="" valign="bottom">
    )
</td>
</tr>
<tr valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Deferred tax liabilities non-current
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    (45.0
</td>
<td align="left" nowrap="" valign="bottom">
    )
</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Other non-current liabilities
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    (2.6
</td>
<td align="left" nowrap="" valign="bottom">
    )
</td>
</tr>
<tr style="font-size: 1pt" valign="bottom">
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 1px solid #000000">

</td>
<td>

</td>
</tr>
<tr valign="bottom">
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    209.2
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr style="font-size: 1pt" valign="bottom">
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 3px double #000000">

</td>
<td>

</td>
</tr>
</table>
<div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
</div>
<div style="margin-top: 12pt; font-size: 1pt"></div>
<div align="left" style="margin-left: 4%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">
<b><i><font style="font-family: 'Times New Roman', Times">Inamed
    Acquisition</font></i></b>
</div>
<div style="margin-top: 6pt; font-size: 1pt"></div>
<div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    On March23, 2006, we completed the acquisition of Inamed,
    a global healthcare company that develops, manufactures and
    markets a diverse line of products, including breast implants, a
    range of facial aesthetics and obesity intervention products,
    for approximately $3.3billion, consisting of approximately
    $1.4billion in cash and 34,883,386shares of our
    common stock with a fair value of approximately
    $1.9billion. See Note2, Acquisitions, in
    the notes to our consolidated financial statements listed under
    Item15 of PartIV of this report, Exhibits and
    Financial Statement Schedules.
</div>
<div style="margin-top: 12pt; font-size: 1pt"></div>
<div align="left" style="margin-left: 4%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">
<b><i><font style="font-family: 'Times New Roman', Times">Contractual
    Obligations and Commitments</font></i></b>
</div>
<div style="margin-top: 6pt; font-size: 1pt"></div>
<div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The table below presents information about our contractual
    obligations and commitments at December31, 2007:
</div>
<table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF" width="100%">
<!-- Table Width Row BEGIN -->
<tr style="font-size: 1pt" valign="bottom">
<td width="51%"></td> <!-- colindex=01 type=maindata -->
<td width="2%"></td> <!-- colindex=02 type=gutter -->
<td align="right" width="3%"></td> <!-- colindex=02 type=lead -->
<td align="right" width="1%"></td> <!-- colindex=02 type=body -->
<td align="left" width="3%"></td> <!-- colindex=02 type=hang1 -->
<td width="3%"></td> <!-- colindex=03 type=gutter -->
<td align="right" width="3%"></td> <!-- colindex=03 type=lead -->
<td align="right" width="1%"></td> <!-- colindex=03 type=body -->
<td align="left" width="3%"></td> <!-- colindex=03 type=hang1 -->
<td width="3%"></td> <!-- colindex=04 type=gutter -->
<td align="right" width="3%"></td> <!-- colindex=04 type=lead -->
<td align="right" width="1%"></td> <!-- colindex=04 type=body -->
<td align="left" width="3%"></td> <!-- colindex=04 type=hang1 -->
<td width="3%"></td> <!-- colindex=05 type=gutter -->
<td align="right" width="3%"></td> <!-- colindex=05 type=lead -->
<td align="right" width="1%"></td> <!-- colindex=05 type=body -->
<td align="left" width="3%"></td> <!-- colindex=05 type=hang1 -->
<td width="3%"></td> <!-- colindex=06 type=gutter -->
<td align="right" width="3%"></td> <!-- colindex=06 type=lead -->
<td align="right" width="1%"></td> <!-- colindex=06 type=body -->
<td align="left" width="3%"></td> <!-- colindex=06 type=hang1 -->
</tr>
<!-- Table Width Row END -->
<tr align="center" style="font-size: 8pt" valign="bottom">
<td align="center" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="19" style="border-bottom: 1px solid #000000" valign="bottom">
<b>Payments Due by Period</b>
</td>
</tr>
<tr align="center" style="font-size: 8pt" valign="bottom">
<td align="center" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" valign="bottom">
<b>More<br/>
</b>
</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" valign="bottom">

</td>
</tr>
<tr align="center" style="font-size: 8pt" valign="bottom">
<td align="center" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" valign="bottom">
<b>Less than<br/>
</b>
</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" valign="bottom">
<b>than Five<br/>
</b>
</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" valign="bottom">

</td>
</tr>
<tr align="center" style="font-size: 8pt" valign="bottom">
<td align="center" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" style="border-bottom: 1px solid #000000" valign="bottom">
<b>One Year</b>
</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" style="border-bottom: 1px solid #000000" valign="bottom">
<b>1-3Years</b>
</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" style="border-bottom: 1px solid #000000" valign="bottom">
<b>3-5Years</b>
</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" style="border-bottom: 1px solid #000000" valign="bottom">
<b>Years</b>
</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" style="border-bottom: 1px solid #000000" valign="bottom">
<b>Total</b>
</td>
</tr>
<tr align="center" style="font-size: 8pt" valign="bottom">
<td align="center" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="19" valign="bottom">
<b>(in millions)</b>
</td>
</tr>
<tr style="line-height: 3pt; font-size: 1pt">
<td>
</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Notes payable, convertible notes and long-term debt
    obligations(a)
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    39.7
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    775.0
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    798.1
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    1,612.8
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Operating lease obligations
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    42.4
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    58.2
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    29.8
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    51.1
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    181.5
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Purchase obligations
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    200.5
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    71.2
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    40.3
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    50.3
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    362.3
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Pension minimum funding(b)
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    18.9
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    36.5
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    34.3
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    89.7
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Other long-term liabilities (including unrecognized tax benefit
    liabilities but excluding deferred income and pension
    liabilities) reflected on our consolidated balance sheet
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    46.7
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    2.6
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    125.3
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    174.6
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr style="font-size: 1pt" valign="bottom">
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 1px solid #000000">

</td>
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 1px solid #000000">

</td>
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 1px solid #000000">

</td>
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 1px solid #000000">

</td>
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 1px solid #000000">

</td>
<td>

</td>
</tr>
<tr valign="bottom">
<td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Total
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    301.5
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    212.6
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    882.0
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    1,024.8
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    2,420.9
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr style="font-size: 1pt" valign="bottom">
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 3px double #000000">

</td>
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 3px double #000000">

</td>
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 3px double #000000">

</td>
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 3px double #000000">

</td>
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 3px double #000000">

</td>
<td>

</td>
</tr>
</table>
<div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
</div>
<div style="font-size: 1pt; margin-left: 0%; width: 13%; align: left; border-bottom: 1pt solid #000000"></div><!-- callerid=999 iwidth=455 length=60 -->
<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF" width="100%">
<tr>
<td width="4%"></td>
<td width="1%"></td>
<td width="95%"></td>
</tr>
<tr>
<td valign="top">
    (a) </td>
<td></td>
<td valign="bottom">
    Excludes the interest rate swap fair value adjustment of
    $17.1million.</td>
</tr>
<tr style="line-height: 3pt; font-size: 1pt"><td></td></tr>
<tr>
<td valign="top">
    (b) </td>
<td></td>
<td valign="bottom">
    For purposes of this table, we assume that we will be required
    to fund our U.S. and
    <font style="white-space: nowrap">non-U.S.</font>
    funded pension plans based on the minimum funding required by
    applicable regulations. In determining the minimum required
    funding, we utilize current actuarial assumptions and exchange
    rates to forecast estimates of amounts that may be payable for
    up to five years in the future. In managements judgment,
    minimum funding estimates beyond a five year time horizon cannot
    be reliably estimated. Where minimum funding as determined for
    each individual plan would not achieve a funded status to the
    level of local statutory requirements, additional discretionary
    funding may be provided from available cash resources.</td>
</tr>
</table>
<p align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<br/>
    73
</p></div><br /><hr noshade=""/><hr noshade=""/><br /><b><i><font style="font-family: 'Times New Roman', Times">Inamed
    Acquisition</font></i></b><div style="margin-top: 6pt; font-size: 1pt"></div><div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    On March23, 2006, we completed the acquisition of Inamed,
    a global healthcare company that develops, manufactures and
    markets a diverse line of products, including breast implants, a
    range of facial aesthetics and obesity intervention products,
    for approximately $3.3billion, consisting of approximately
    $1.4billion in cash and 34,883,386shares of our
    common stock with a fair value of approximately
    $1.9billion. See Note2, Acquisitions, in
    the notes to our consolidated financial statements listed under
    Item15 of PartIV of this report, Exhibits and
    Financial Statement Schedules.
</div><div style="margin-top: 12pt; font-size: 1pt"></div><div align="left" style="margin-left: 4%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">
<b><i><font style="font-family: 'Times New Roman', Times">Contractual
    Obligations and Commitments</font></i></b>
</div><b><i><font style="font-family: 'Times New Roman', Times">Contractual
    Obligations and Commitments</font></i></b><div style="margin-top: 6pt; font-size: 1pt"></div><div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The table below presents information about our contractual
    obligations and commitments at December31, 2007:
</div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF" width="100%">
<!-- Table Width Row BEGIN -->
<tr style="font-size: 1pt" valign="bottom">
<td width="51%"></td> <!-- colindex=01 type=maindata -->
<td width="2%"></td> <!-- colindex=02 type=gutter -->
<td align="right" width="3%"></td> <!-- colindex=02 type=lead -->
<td align="right" width="1%"></td> <!-- colindex=02 type=body -->
<td align="left" width="3%"></td> <!-- colindex=02 type=hang1 -->
<td width="3%"></td> <!-- colindex=03 type=gutter -->
<td align="right" width="3%"></td> <!-- colindex=03 type=lead -->
<td align="right" width="1%"></td> <!-- colindex=03 type=body -->
<td align="left" width="3%"></td> <!-- colindex=03 type=hang1 -->
<td width="3%"></td> <!-- colindex=04 type=gutter -->
<td align="right" width="3%"></td> <!-- colindex=04 type=lead -->
<td align="right" width="1%"></td> <!-- colindex=04 type=body -->
<td align="left" width="3%"></td> <!-- colindex=04 type=hang1 -->
<td width="3%"></td> <!-- colindex=05 type=gutter -->
<td align="right" width="3%"></td> <!-- colindex=05 type=lead -->
<td align="right" width="1%"></td> <!-- colindex=05 type=body -->
<td align="left" width="3%"></td> <!-- colindex=05 type=hang1 -->
<td width="3%"></td> <!-- colindex=06 type=gutter -->
<td align="right" width="3%"></td> <!-- colindex=06 type=lead -->
<td align="right" width="1%"></td> <!-- colindex=06 type=body -->
<td align="left" width="3%"></td> <!-- colindex=06 type=hang1 -->
</tr>
<!-- Table Width Row END -->
<tr align="center" style="font-size: 8pt" valign="bottom">
<td align="center" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="19" style="border-bottom: 1px solid #000000" valign="bottom">
<b>Payments Due by Period</b>
</td>
</tr>
<tr align="center" style="font-size: 8pt" valign="bottom">
<td align="center" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" valign="bottom">
<b>More<br/>
</b>
</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" valign="bottom">

</td>
</tr>
<tr align="center" style="font-size: 8pt" valign="bottom">
<td align="center" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" valign="bottom">
<b>Less than<br/>
</b>
</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" valign="bottom">
<b>than Five<br/>
</b>
</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" valign="bottom">

</td>
</tr>
<tr align="center" style="font-size: 8pt" valign="bottom">
<td align="center" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" style="border-bottom: 1px solid #000000" valign="bottom">
<b>One Year</b>
</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" style="border-bottom: 1px solid #000000" valign="bottom">
<b>1-3Years</b>
</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" style="border-bottom: 1px solid #000000" valign="bottom">
<b>3-5Years</b>
</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" style="border-bottom: 1px solid #000000" valign="bottom">
<b>Years</b>
</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" style="border-bottom: 1px solid #000000" valign="bottom">
<b>Total</b>
</td>
</tr>
<tr align="center" style="font-size: 8pt" valign="bottom">
<td align="center" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="19" valign="bottom">
<b>(in millions)</b>
</td>
</tr>
<tr style="line-height: 3pt; font-size: 1pt">
<td>
</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Notes payable, convertible notes and long-term debt
    obligations(a)
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    39.7
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    775.0
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    798.1
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    1,612.8
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Operating lease obligations
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    42.4
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    58.2
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    29.8
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    51.1
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    181.5
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Purchase obligations
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    200.5
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    71.2
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    40.3
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    50.3
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    362.3
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Pension minimum funding(b)
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    18.9
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    36.5
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    34.3
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    89.7
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Other long-term liabilities (including unrecognized tax benefit
    liabilities but excluding deferred income and pension
    liabilities) reflected on our consolidated balance sheet
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    46.7
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    2.6
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    125.3
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    174.6
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr style="font-size: 1pt" valign="bottom">
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 1px solid #000000">

</td>
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 1px solid #000000">

</td>
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 1px solid #000000">

</td>
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 1px solid #000000">

</td>
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 1px solid #000000">

</td>
<td>

</td>
</tr>
<tr valign="bottom">
<td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Total
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    301.5
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    212.6
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    882.0
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    1,024.8
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    2,420.9
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr style="font-size: 1pt" valign="bottom">
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 3px double #000000">

</td>
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 3px double #000000">

</td>
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 3px double #000000">

</td>
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 3px double #000000">

</td>
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 3px double #000000">

</td>
<td>

</td>
</tr>
</table><tr style="font-size: 1pt" valign="bottom">
<td width="51%"></td> <!-- colindex=01 type=maindata -->
<td width="2%"></td> <!-- colindex=02 type=gutter -->
<td align="right" width="3%"></td> <!-- colindex=02 type=lead -->
<td align="right" width="1%"></td> <!-- colindex=02 type=body -->
<td align="left" width="3%"></td> <!-- colindex=02 type=hang1 -->
<td width="3%"></td> <!-- colindex=03 type=gutter -->
<td align="right" width="3%"></td> <!-- colindex=03 type=lead -->
<td align="right" width="1%"></td> <!-- colindex=03 type=body -->
<td align="left" width="3%"></td> <!-- colindex=03 type=hang1 -->
<td width="3%"></td> <!-- colindex=04 type=gutter -->
<td align="right" width="3%"></td> <!-- colindex=04 type=lead -->
<td align="right" width="1%"></td> <!-- colindex=04 type=body -->
<td align="left" width="3%"></td> <!-- colindex=04 type=hang1 -->
<td width="3%"></td> <!-- colindex=05 type=gutter -->
<td align="right" width="3%"></td> <!-- colindex=05 type=lead -->
<td align="right" width="1%"></td> <!-- colindex=05 type=body -->
<td align="left" width="3%"></td> <!-- colindex=05 type=hang1 -->
<td width="3%"></td> <!-- colindex=06 type=gutter -->
<td align="right" width="3%"></td> <!-- colindex=06 type=lead -->
<td align="right" width="1%"></td> <!-- colindex=06 type=body -->
<td align="left" width="3%"></td> <!-- colindex=06 type=hang1 -->
</tr><td width="51%"></td><tr align="center" style="font-size: 8pt" valign="bottom">
<td align="center" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="19" style="border-bottom: 1px solid #000000" valign="bottom">
<b>Payments Due by Period</b>
</td>
</tr><td align="center" nowrap="" valign="bottom">

</td><td align="center" colspan="19" style="border-bottom: 1px solid #000000" valign="bottom">
<b>Payments Due by Period</b>
</td><b>Payments Due by Period</b><tr align="center" style="font-size: 8pt" valign="bottom">
<td align="center" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" valign="bottom">
<b>More<br/>
</b>
</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" valign="bottom">

</td>
</tr><td align="center" nowrap="" valign="bottom">

</td><td align="center" colspan="3" nowrap="" valign="bottom">
<b>More<br/>
</b>
</td><b>More<br/>
</b><br/><td>

</td><tr align="center" style="font-size: 8pt" valign="bottom">
<td align="center" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" valign="bottom">
<b>Less than<br/>
</b>
</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" valign="bottom">
<b>than Five<br/>
</b>
</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" valign="bottom">

</td>
</tr><td align="center" nowrap="" valign="bottom">

</td><td align="center" colspan="3" nowrap="" valign="bottom">
<b>Less than<br/>
</b>
</td><b>Less than<br/>
</b><br/><td>

</td><td align="center" colspan="3" nowrap="" valign="bottom">
<b>than Five<br/>
</b>
</td><b>than Five<br/>
</b><br/><td>

</td><tr align="center" style="font-size: 8pt" valign="bottom">
<td align="center" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" style="border-bottom: 1px solid #000000" valign="bottom">
<b>One Year</b>
</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" style="border-bottom: 1px solid #000000" valign="bottom">
<b>1-3Years</b>
</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" style="border-bottom: 1px solid #000000" valign="bottom">
<b>3-5Years</b>
</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" style="border-bottom: 1px solid #000000" valign="bottom">
<b>Years</b>
</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" style="border-bottom: 1px solid #000000" valign="bottom">
<b>Total</b>
</td>
</tr><td align="center" nowrap="" valign="bottom">

</td><td align="center" colspan="3" nowrap="" style="border-bottom: 1px solid #000000" valign="bottom">
<b>One Year</b>
</td><b>One Year</b><td>

</td><td align="center" colspan="3" nowrap="" style="border-bottom: 1px solid #000000" valign="bottom">
<b>1-3Years</b>
</td><b>1-3Years</b><td>

</td><td align="center" colspan="3" nowrap="" style="border-bottom: 1px solid #000000" valign="bottom">
<b>3-5Years</b>
</td><b>3-5Years</b><td>

</td><td align="center" colspan="3" nowrap="" style="border-bottom: 1px solid #000000" valign="bottom">
<b>Years</b>
</td><b>Years</b><td>

</td><td align="center" colspan="3" nowrap="" style="border-bottom: 1px solid #000000" valign="bottom">
<b>Total</b>
</td><b>Total</b><tr align="center" style="font-size: 8pt" valign="bottom">
<td align="center" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="19" valign="bottom">
<b>(in millions)</b>
</td>
</tr><td align="center" nowrap="" valign="bottom">

</td><td align="center" colspan="19" valign="bottom">
<b>(in millions)</b>
</td><b>(in millions)</b><tr style="line-height: 3pt; font-size: 1pt">
<td>
</td>
</tr><td>
</td><tr style="background: #CCEEFF" valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Notes payable, convertible notes and long-term debt
    obligations(a)
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    39.7
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    775.0
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    798.1
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    1,612.8
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr><td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Notes payable, convertible notes and long-term debt
    obligations(a)
</div>
</td><div style="text-indent: -10pt; margin-left: 10pt">
    Notes payable, convertible notes and long-term debt
    obligations(a)
</div><td>

</td><td align="right" nowrap="" valign="bottom">
    $
</td><td align="right" nowrap="" valign="bottom">
    39.7
</td><td align="left" nowrap="" valign="bottom">

</td><td align="right" nowrap="" valign="bottom">
    $
</td><td align="right" nowrap="" valign="bottom">
    
</td><td align="left" nowrap="" valign="bottom">

</td><td align="right" nowrap="" valign="bottom">
    $
</td><td align="right" nowrap="" valign="bottom">
    775.0
</td><td align="left" nowrap="" valign="bottom">

</td><td align="right" nowrap="" valign="bottom">
    $
</td><td align="right" nowrap="" valign="bottom">
    798.1
</td><td align="left" nowrap="" valign="bottom">

</td><td align="right" nowrap="" valign="bottom">
    $
</td><td align="right" nowrap="" valign="bottom">
    1,612.8
</td><td align="left" nowrap="" valign="bottom">

</td><tr valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Operating lease obligations
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    42.4
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    58.2
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    29.8
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    51.1
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    181.5
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr><td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Operating lease obligations
</div>
</td><div style="text-indent: -10pt; margin-left: 10pt">
    Operating lease obligations
</div><td>

</td><td align="right" nowrap="" valign="bottom">
    42.4
</td><td align="left" nowrap="" valign="bottom">

</td><td align="right" nowrap="" valign="bottom">
    58.2
</td><td align="left" nowrap="" valign="bottom">

</td><td align="right" nowrap="" valign="bottom">
    29.8
</td><td align="left" nowrap="" valign="bottom">

</td><td align="right" nowrap="" valign="bottom">
    51.1
</td><td align="left" nowrap="" valign="bottom">

</td><td align="right" nowrap="" valign="bottom">
    181.5
</td><td align="left" nowrap="" valign="bottom">

</td><tr style="background: #CCEEFF" valign="bottom">
<td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Purchase obligations
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    200.5
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    71.2
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    40.3
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    50.3
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    362.3
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr><td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Purchase obligations
</div>
</td><div style="text-indent: -10pt; margin-left: 10pt">
    Purchase obligations
</div><td>

</td><td align="right" nowrap="" valign="bottom">
    200.5
</td><td align="left" nowrap="" valign="bottom">

</td><td align="right" nowrap="" valign="bottom">
    71.2
</td><td align="left" nowrap="" valign="bottom">

</td><td align="right" nowrap="" valign="bottom">
    40.3
</td><td align="left" nowrap="" valign="bottom">

</td><td align="right" nowrap="" valign="bottom">
    50.3
</td><td align="left" nowrap="" valign="bottom">

</td><td align="right" nowrap="" valign="bottom">
    362.3
</td><td align="left" nowrap="" valign="bottom">

</td><tr valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Pension minimum funding(b)
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    18.9
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    36.5
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    34.3
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    89.7
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr><td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Pension minimum funding(b)
</div>
</td><div style="text-indent: -10pt; margin-left: 10pt">
    Pension minimum funding(b)
</div><td>

</td><td align="right" nowrap="" valign="bottom">
    18.9
</td><td align="left" nowrap="" valign="bottom">

</td><td align="right" nowrap="" valign="bottom">
    36.5
</td><td align="left" nowrap="" valign="bottom">

</td><td align="right" nowrap="" valign="bottom">
    34.3
</td><td align="left" nowrap="" valign="bottom">

</td><td align="right" nowrap="" valign="bottom">
    
</td><td align="left" nowrap="" valign="bottom">

</td><td align="right" nowrap="" valign="bottom">
    89.7
</td><td align="left" nowrap="" valign="bottom">

</td><tr style="background: #CCEEFF" valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Other long-term liabilities (including unrecognized tax benefit
    liabilities but excluding deferred income and pension
    liabilities) reflected on our consolidated balance sheet
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    46.7
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    2.6
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    125.3
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    174.6
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr><br /><hr noshade=""/><hr noshade=""/><br /><b><font style="font-family: 'Times New Roman', Times">Acquisitions</font></b><div style="margin-top: 6pt; font-size: 1pt"></div><div align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">
<b><i><font style="font-family: 'Times New Roman', Times">Esprit
    Acquisition</font></i></b>
</div><b><i><font style="font-family: 'Times New Roman', Times">Esprit
    Acquisition</font></i></b><div style="margin-top: 6pt; font-size: 1pt"></div><div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    On October16, 2007, the Company completed the acquisition
    of Esprit, a pharmaceutical company based in the United States
    with expertise in the genitourinary market, for an aggregate
    purchase price of approximately $370.7million, net of cash
    acquired. In connection with the acquisition, the Company
    acquired assets with a fair value of $525.0million and
    assumed liabilities of $154.3million. The Esprit
    acquisition was completed pursuant to an Agreement and Plan of
    Merger, dated as of September18, 2007 (Merger Agreement),
    by and among the Company, Esmeralde Acquisition, Inc., a
    wholly-owned subsidiary of the Company (Merger Sub), Esprit and
    the Escrow Participants Representative named in the Merger
    Agreement. Pursuant to the Merger Agreement, Merger Sub was
    merged with and into Esprit, with Esprit surviving and becoming
    a wholly-owned subsidiary of the Company. The acquisition was
    funded from current cash and equivalent balances. Prior to and
    in anticipation of the acquisition, the Company loaned Esprit
    $74.8million in August 2007, the proceeds of which were
    used by Esprit to fund a milestone payment to a third party and
    to repay certain outstanding obligations to third-party lenders.
    The loan was secured by all of the assets of Esprit. The terms
    of the loan were at fair value. The loan and accrued interest of
    $0.9million were effectively settled upon the acquisition
    with no resulting gain or loss. The Esprit acquisition provides
    the Company with a dedicated urologics product line within its
    specialty pharmaceuticals segment.
</div><p align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<br/>
    F-14
</p><br/><p>
</p><h5 align="left" style="page-break-before:always"><a href="#tocpage">Table of Contents</a></h5><p>
</p><div style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->
<div style="margin-top: 18pt; font-size: 1pt"></div>
<div align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">
<b><font style="font-family: 'Times New Roman', Times">ALLERGAN,
    INC.<br/>
</font></b>
</div>
<div style="margin-top: 6pt; font-size: 1pt"></div>
<div align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">
<b><font style="font-family: 'Times New Roman', Times">NOTESTO
    CONSOLIDATED FINANCIAL
    STATEMENTS(Continued)</font></b>
</div>
<div style="margin-top: 18pt; font-size: 1pt"></div>
<div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The following table summarizes the components of the Esprit
    purchase price:
</div>
<div style="margin-top: 6pt; font-size: 1pt"></div>
<table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF" width="100%">
<!-- Table Width Row BEGIN -->
<tr style="font-size: 1pt" valign="bottom">
<td width="89%"></td> <!-- colindex=01 type=maindata -->
<td width="2%"></td> <!-- colindex=02 type=gutter -->
<td align="right" width="4%"></td> <!-- colindex=02 type=lead -->
<td align="right" width="1%"></td> <!-- colindex=02 type=body -->
<td align="left" width="4%"></td> <!-- colindex=02 type=hang1 -->
</tr>
<!-- Table Width Row END -->
<tr align="center" style="font-size: 8pt" valign="bottom">
<td align="center" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" valign="bottom">
<b>(in millions)</b>
</td>
</tr>
<tr style="line-height: 3pt; font-size: 1pt">
<td>
</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Cash consideration, net of cash acquired
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    288.6
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr valign="bottom">
<td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Transaction costs
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    6.4
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr style="font-size: 1pt" valign="bottom">
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 1px solid #000000">

</td>
<td>

</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Cash paid
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    295.0
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Settlement of a pre-existing loan from Allergan to Esprit plus
    accrued interest
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    75.7
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr style="font-size: 1pt" valign="bottom">
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 1px solid #000000">

</td>
<td>

</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    370.7
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr style="font-size: 1pt" valign="bottom">
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 3px double #000000">

</td>
<td>

</td>
</tr>
</table>
<div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
</div>
<div style="margin-top: 12pt; font-size: 1pt"></div>
<div align="left" style="margin-left: 4%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">
<b><i><font style="font-family: 'Times New Roman', Times">Purchase
    Price Allocation</font></i></b>
</div>
<div style="margin-top: 6pt; font-size: 1pt"></div>
<div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Esprit purchase price was allocated to tangible and
    intangible assets acquired and liabilities assumed based on
    their estimated fair values at the acquisition date. The excess
    of the purchase price over the fair value of net assets acquired
    was allocated to goodwill. The goodwill acquired in the Esprit
    acquisition is not deductible for tax purposes.
</div>
<div style="margin-top: 6pt; font-size: 1pt"></div>
<div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Company believes the fair values assigned to the Esprit
    assets acquired and liabilities assumed were based on reasonable
    assumptions. The following table summarizes the estimated fair
    values of net assets acquired:
</div>
<div style="margin-top: 6pt; font-size: 1pt"></div>
<table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF" width="100%">
<!-- Table Width Row BEGIN -->
<tr style="font-size: 1pt" valign="bottom">
<td width="89%"></td> <!-- colindex=01 type=maindata -->
<td width="2%"></td> <!-- colindex=02 type=gutter -->
<td align="right" width="4%"></td> <!-- colindex=02 type=lead -->
<td align="right" width="1%"></td> <!-- colindex=02 type=body -->
<td align="left" width="4%"></td> <!-- colindex=02 type=hang1 -->
</tr>
<!-- Table Width Row END -->
<tr align="center" style="font-size: 8pt" valign="bottom">
<td align="center" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" valign="bottom">
<b>(in millions)</b>
</td>
</tr>
<tr style="line-height: 3pt; font-size: 1pt">
<td>
</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Current assets
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    35.8
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Identifiable intangible asset
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    358.0
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Goodwill
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    122.6
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Other non-current assets
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    8.6
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Accounts payable and accrued liabilities
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    (24.2
</td>
<td align="left" nowrap="" valign="bottom">
    )
</td>
</tr>
<tr valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Deferred tax liabilities current and non-current
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    (128.9
</td>
<td align="left" nowrap="" valign="bottom">
    )
</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Other non-current liabilities
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    (1.2
</td>
<td align="left" nowrap="" valign="bottom">
    )
</td>
</tr>
<tr style="font-size: 1pt" valign="bottom">
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 1px solid #000000">

</td>
<td>

</td>
</tr>
<tr valign="bottom">
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    370.7
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr style="font-size: 1pt" valign="bottom">
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 3px double #000000">

</td>
<td>

</td>
</tr>
</table>
<div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
</div>
<div style="margin-top: 6pt; font-size: 1pt"></div>
<div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Companys fair value estimates for the Esprit purchase
    price allocation may change during the allowable allocation
    period, which is currently up to one year from the acquisition
    date, if additional information becomes available.
</div>
<div style="margin-top: 12pt; font-size: 1pt"></div>
<div align="left" style="margin-left: 4%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">
<b><i><font style="font-family: 'Times New Roman', Times">In-process
    Research and Development</font></i></b>
</div>
<div style="margin-top: 6pt; font-size: 1pt"></div>
<div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In conjunction with the Esprit acquisition, the Company
    determined that the R&amp;D efforts related to Esprit products
    did not give rise to identifiable in-process research and
    development assets with anticipated future economic value that
    could be reasonably estimated.
</div>
<div style="margin-top: 12pt; font-size: 1pt"></div>
<div align="left" style="margin-left: 4%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">
<b><i><font style="font-family: 'Times New Roman', Times">Identifiable
    Intangible Asset</font></i></b>
</div>
<div style="margin-top: 6pt; font-size: 1pt"></div>
<div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The acquired identifiable intangible asset consists of product
    rights for developed technology for an approved indication in
    the United States at the acquisition date for <i>Sanctura
    XR</i><sup style="font-size: 85%; vertical-align: text-top"><font style="font-variant: SMALL-CAPS">tm</font></sup>,
    a once-daily oral drug treatment for overactive bladder. The
    useful life of this intangible asset was determined to be
    16years.
</div>
<div style="margin-top: 6pt; font-size: 1pt"></div>
<div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Impairment evaluations in the future for the acquired developed
    technology will occur at a consolidated cash flow level within
    the Companys specialty pharmaceuticals segment in the
    United States, the market used to originally value the
    intangible asset.
</div>
<p align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<br/>
    F-15
</p></div><div style="margin-top: 18pt; font-size: 1pt"></div><div align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">
<b><font style="font-family: 'Times New Roman', Times">ALLERGAN,
    INC.<br/>
</font></b>
</div><b><font style="font-family: 'Times New Roman', Times">ALLERGAN,
    INC.<br/>
</font></b><br/><div style="margin-top: 6pt; font-size: 1pt"></div><div align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">
<b><font style="font-family: 'Times New Roman', Times">NOTESTO
    CONSOLIDATED FINANCIAL
    STATEMENTS(Continued)</font></b>
</div><b><font style="font-family: 'Times New Roman', Times">NOTESTO
    CONSOLIDATED FINANCIAL
    STATEMENTS(Continued)</font></b><div style="margin-top: 18pt; font-size: 1pt"></div><div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The following table summarizes the components of the Esprit
    purchase price:
</div><div style="margin-top: 6pt; font-size: 1pt"></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF" width="100%">
<!-- Table Width Row BEGIN -->
<tr style="font-size: 1pt" valign="bottom">
<td width="89%"></td> <!-- colindex=01 type=maindata -->
<td width="2%"></td> <!-- colindex=02 type=gutter -->
<td align="right" width="4%"></td> <!-- colindex=02 type=lead -->
<td align="right" width="1%"></td> <!-- colindex=02 type=body -->
<td align="left" width="4%"></td> <!-- colindex=02 type=hang1 -->
</tr>
<!-- Table Width Row END -->
<tr align="center" style="font-size: 8pt" valign="bottom">
<td align="center" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" valign="bottom">
<b>(in millions)</b>
</td>
</tr>
<tr style="line-height: 3pt; font-size: 1pt">
<td>
</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Cash consideration, net of cash acquired
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    288.6
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr valign="bottom">
<td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Transaction costs
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    6.4
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr style="font-size: 1pt" valign="bottom">
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 1px solid #000000">

</td>
<td>

</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Cash paid
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    295.0
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Settlement of a pre-existing loan from Allergan to Esprit plus
    accrued interest
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    75.7
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr style="font-size: 1pt" valign="bottom">
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 1px solid #000000">

</td>
<td>

</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    370.7
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr style="font-size: 1pt" valign="bottom">
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 3px double #000000">

</td>
<td>

</td>
</tr>
</table><tr style="font-size: 1pt" valign="bottom">
<td width="89%"></td> <!-- colindex=01 type=maindata -->
<td width="2%"></td> <!-- colindex=02 type=gutter -->
<td align="right" width="4%"></td> <!-- colindex=02 type=lead -->
<td align="right" width="1%"></td> <!-- colindex=02 type=body -->
<td align="left" width="4%"></td> <!-- colindex=02 type=hang1 -->
</tr><td width="89%"></td><tr align="center" style="font-size: 8pt" valign="bottom">
<td align="center" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" valign="bottom">
<b>(in millions)</b>
</td>
</tr><td align="center" nowrap="" valign="bottom">

</td><td align="center" colspan="3" nowrap="" valign="bottom">
<b>(in millions)</b>
</td><b>(in millions)</b><tr style="line-height: 3pt; font-size: 1pt">
<td>
</td>
</tr><td>
</td><tr style="background: #CCEEFF" valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Cash consideration, net of cash acquired
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    288.6
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr><td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Cash consideration, net of cash acquired
</div>
</td><div style="text-indent: -10pt; margin-left: 10pt">
    Cash consideration, net of cash acquired
</div><td>

</td><td align="right" nowrap="" valign="bottom">
    $
</td><td align="right" nowrap="" valign="bottom">
    288.6
</td><td align="left" nowrap="" valign="bottom">

</td><tr valign="bottom">
<td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Transaction costs
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    6.4
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr><td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Transaction costs
</div>
</td><div style="text-indent: -10pt; margin-left: 10pt">
    Transaction costs
</div><td>

</td><td align="right" nowrap="" valign="bottom">
    6.4
</td><td align="left" nowrap="" valign="bottom">

</td><tr style="font-size: 1pt" valign="bottom">
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 1px solid #000000">

</td>
<td>

</td>
</tr><td>

</td><tr style="background: #CCEEFF" valign="bottom">
<td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Cash paid
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    295.0
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr><td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Cash paid
</div>
</td><div style="text-indent: -10pt; margin-left: 10pt">
    Cash paid
</div><td>

</td><td align="right" nowrap="" valign="bottom">
    295.0
</td><td align="left" nowrap="" valign="bottom">

</td><tr valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Settlement of a pre-existing loan from Allergan to Esprit plus
    accrued interest
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    75.7
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr><td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Settlement of a pre-existing loan from Allergan to Esprit plus
    accrued interest
</div>
</td><div style="text-indent: -10pt; margin-left: 10pt">
    Settlement of a pre-existing loan from Allergan to Esprit plus
    accrued interest
</div><td>

</td><td align="right" nowrap="" valign="bottom">
    75.7
</td><td align="left" nowrap="" valign="bottom">

</td><tr style="font-size: 1pt" valign="bottom">
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 1px solid #000000">

</td>
<td>

</td>
</tr><td>

</td><tr style="background: #CCEEFF" valign="bottom">
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    370.7
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr><td align="left" nowrap="" valign="bottom">

</td><td align="right" nowrap="" valign="bottom">
    $
</td><td align="right" nowrap="" valign="bottom">
    370.7
</td><td align="left" nowrap="" valign="bottom">

</td><tr style="font-size: 1pt" valign="bottom">
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 3px double #000000">

</td>
<td>

</td>
</tr><td>

</td><div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
</div><div style="margin-top: 12pt; font-size: 1pt"></div><div align="left" style="margin-left: 4%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">
<b><i><font style="font-family: 'Times New Roman', Times">Purchase
    Price Allocation</font></i></b>
</div><b><i><font style="font-family: 'Times New Roman', Times">Purchase
    Price Allocation</font></i></b><div style="margin-top: 6pt; font-size: 1pt"></div><div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Esprit purchase price was allocated to tangible and
    intangible assets acquired and liabilities assumed based on
    their estimated fair values at the acquisition date. The excess
    of the purchase price over the fair value of net assets acquired
    was allocated to goodwill. The goodwill acquired in the Esprit
    acquisition is not deductible for tax purposes.
</div><div style="margin-top: 6pt; font-size: 1pt"></div><div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Company believes the fair values assigned to the Esprit
    assets acquired and liabilities assumed were based on reasonable
    assumptions. The following table summarizes the estimated fair
    values of net assets acquired:
</div><div style="margin-top: 6pt; font-size: 1pt"></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF" width="100%">
<!-- Table Width Row BEGIN -->
<tr style="font-size: 1pt" valign="bottom">
<td width="89%"></td> <!-- colindex=01 type=maindata -->
<td width="2%"></td> <!-- colindex=02 type=gutter -->
<td align="right" width="4%"></td> <!-- colindex=02 type=lead -->
<td align="right" width="1%"></td> <!-- colindex=02 type=body -->
<td align="left" width="4%"></td> <!-- colindex=02 type=hang1 -->
</tr>
<!-- Table Width Row END -->
<tr align="center" style="font-size: 8pt" valign="bottom">
<td align="center" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" valign="bottom">
<b>(in millions)</b>
</td>
</tr>
<tr style="line-height: 3pt; font-size: 1pt">
<td>
</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Current assets
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    35.8
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Identifiable intangible asset
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    358.0
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Goodwill
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    122.6
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Other non-current assets
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    8.6
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Accounts payable and accrued liabilities
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    (24.2
</td>
<td align="left" nowrap="" valign="bottom">
    )
</td>
</tr>
<tr valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Deferred tax liabilities current and non-current
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    (128.9
</td>
<td align="left" nowrap="" valign="bottom">
    )
</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Other non-current liabilities
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    (1.2
</td>
<td align="left" nowrap="" valign="bottom">
    )
</td>
</tr>
<tr style="font-size: 1pt" valign="bottom">
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 1px solid #000000">

</td>
<td>

</td>
</tr>
<tr valign="bottom">
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    370.7
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr style="font-size: 1pt" valign="bottom">
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 3px double #000000">

</td>
<td>

</td>
</tr>
</table><tr style="font-size: 1pt" valign="bottom">
<td width="89%"></td> <!-- colindex=01 type=maindata -->
<td width="2%"></td> <!-- colindex=02 type=gutter -->
<td align="right" width="4%"></td> <!-- colindex=02 type=lead -->
<td align="right" width="1%"></td> <!-- colindex=02 type=body -->
<td align="left" width="4%"></td> <!-- colindex=02 type=hang1 -->
</tr><td width="89%"></td><tr align="center" style="font-size: 8pt" valign="bottom">
<td align="center" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" valign="bottom">
<b>(in millions)</b>
</td>
</tr><td align="center" nowrap="" valign="bottom">

</td><td align="center" colspan="3" nowrap="" valign="bottom">
<b>(in millions)</b>
</td><b>(in millions)</b><tr style="line-height: 3pt; font-size: 1pt">
<td>
</td>
</tr><td>
</td><tr style="background: #CCEEFF" valign="bottom">
<td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Current assets
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    35.8
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr><td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Current assets
</div>
</td><div style="text-indent: -10pt; margin-left: 10pt">
    Current assets
</div><td>

</td><td align="right" nowrap="" valign="bottom">
    $
</td><td align="right" nowrap="" valign="bottom">
    35.8
</td><td align="left" nowrap="" valign="bottom">

</td><tr valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Identifiable intangible asset
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    358.0
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr><td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Identifiable intangible asset
</div>
</td><div style="text-indent: -10pt; margin-left: 10pt">
    Identifiable intangible asset
</div><td>

</td><td align="right" nowrap="" valign="bottom">
    358.0
</td><td align="left" nowrap="" valign="bottom">

</td><tr style="background: #CCEEFF" valign="bottom">
<td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Goodwill
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    122.6
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr><td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Goodwill
</div>
</td><div style="text-indent: -10pt; margin-left: 10pt">
    Goodwill
</div><td>

</td><td align="right" nowrap="" valign="bottom">
    122.6
</td><td align="left" nowrap="" valign="bottom">

</td><tr valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Other non-current assets
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    8.6
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr><td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Other non-current assets
</div>
</td><div style="text-indent: -10pt; margin-left: 10pt">
    Other non-current assets
</div><td>

</td><td align="right" nowrap="" valign="bottom">
    8.6
</td><td align="left" nowrap="" valign="bottom">

</td><tr style="background: #CCEEFF" valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Accounts payable and accrued liabilities
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    (24.2
</td>
<td align="left" nowrap="" valign="bottom">
    )
</td>
</tr><td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Accounts payable and accrued liabilities
</div>
</td><div style="text-indent: -10pt; margin-left: 10pt">
    Accounts payable and accrued liabilities
</div><td>

</td><td align="right" nowrap="" valign="bottom">
    (24.2
</td><td align="left" nowrap="" valign="bottom">
    )
</td><tr valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Deferred tax liabilities current and non-current
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    (128.9
</td>
<td align="left" nowrap="" valign="bottom">
    )
</td>
</tr><td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Deferred tax liabilities current and non-current
</div>
</td><div style="text-indent: -10pt; margin-left: 10pt">
    Deferred tax liabilities current and non-current
</div><td>

</td><td align="right" nowrap="" valign="bottom">
    (128.9
</td><td align="left" nowrap="" valign="bottom">
    )
</td><tr style="background: #CCEEFF" valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Other non-current liabilities
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    (1.2
</td>
<td align="left" nowrap="" valign="bottom">
    )
</td>
</tr><td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Other non-current liabilities
</div>
</td><div style="text-indent: -10pt; margin-left: 10pt">
    Other non-current liabilities
</div><td>

</td><td align="right" nowrap="" valign="bottom">
    (1.2
</td><td align="left" nowrap="" valign="bottom">
    )
</td><tr style="font-size: 1pt" valign="bottom">
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 1px solid #000000">

</td>
<td>

</td>
</tr><td>

</td><tr valign="bottom">
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    370.7
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr><td align="left" nowrap="" valign="bottom">

</td><td align="right" nowrap="" valign="bottom">
    $
</td><td align="right" nowrap="" valign="bottom">
    370.7
</td><td align="left" nowrap="" valign="bottom">

</td><tr style="font-size: 1pt" valign="bottom">
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 3px double #000000">

</td>
<td>

</td>
</tr><td>

</td><div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
</div><div style="margin-top: 6pt; font-size: 1pt"></div><div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Companys fair value estimates for the Esprit purchase
    price allocation may change during the allowable allocation
    period, which is currently up to one year from the acquisition
    date, if additional information becomes available.
</div><div style="margin-top: 12pt; font-size: 1pt"></div><div align="left" style="margin-left: 4%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">
<b><i><font style="font-family: 'Times New Roman', Times">In-process
    Research and Development</font></i></b>
</div><b><i><font style="font-family: 'Times New Roman', Times">In-process
    Research and Development</font></i></b><div style="margin-top: 6pt; font-size: 1pt"></div><div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In conjunction with the Esprit acquisition, the Company
    determined that the R&amp;D efforts related to Esprit products
    did not give rise to identifiable in-process research and
    development assets with anticipated future economic value that
    could be reasonably estimated.
</div><div style="margin-top: 12pt; font-size: 1pt"></div><div align="left" style="margin-left: 4%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">
<b><i><font style="font-family: 'Times New Roman', Times">Identifiable
    Intangible Asset</font></i></b>
</div><b><i><font style="font-family: 'Times New Roman', Times">Identifiable
    Intangible Asset</font></i></b><div style="margin-top: 6pt; font-size: 1pt"></div><div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The acquired identifiable intangible asset consists of product
    rights for developed technology for an approved indication in
    the United States at the acquisition date for <i>Sanctura
    XR</i><sup style="font-size: 85%; vertical-align: text-top"><font style="font-variant: SMALL-CAPS">tm</font></sup>,
    a once-daily oral drug treatment for overactive bladder. The
    useful life of this intangible asset was determined to be
    16years.
</div><i>Sanctura
    XR</i><sup style="font-size: 85%; vertical-align: text-top"><font style="font-variant: SMALL-CAPS">tm</font></sup><div style="margin-top: 6pt; font-size: 1pt"></div><div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Impairment evaluations in the future for the acquired developed
    technology will occur at a consolidated cash flow level within
    the Companys specialty pharmaceuticals segment in the
    United States, the market used to originally value the
    intangible asset.
</div><p align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<br/>
    F-15
</p><br/><p>
</p><h5 align="left" style="page-break-before:always"><a href="#tocpage">Table of Contents</a></h5><p>
</p><div style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->
<div style="margin-top: 18pt; font-size: 1pt"></div>
<div align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">
<b><font style="font-family: 'Times New Roman', Times">ALLERGAN,
    INC.<br/>
</font></b>
</div>
<div style="margin-top: 6pt; font-size: 1pt"></div>
<div align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">
<b><font style="font-family: 'Times New Roman', Times">NOTESTO
    CONSOLIDATED FINANCIAL
    STATEMENTS(Continued)</font></b>
</div>
<div style="margin-top: 18pt; font-size: 1pt"></div>
<div align="left" style="margin-left: 4%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">
<b><i><font style="font-family: 'Times New Roman', Times">Goodwill</font></i></b>
</div>
<div style="margin-top: 6pt; font-size: 1pt"></div>
<div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Goodwill represents the excess of the Esprit purchase price over
    the sum of the amounts assigned to assets acquired less
    liabilities assumed. The Company believes that the Esprit
    acquisition will produce the following significant benefits:
</div>
<div style="margin-top: 6pt; font-size: 1pt"></div>
<table border="0" cellpadding="0" cellspacing="0" width="100%">
<tr>
<td width="4%"></td>
<td width="2%"></td>
<td width="94%"></td>
</tr>
<tr style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF" valign="top">
<td></td>
<td>    
</td>
<td align="left">
<i>Increased Market Presence and
    Opportunities.</i>The acquisition of Esprit should
    enable the Company to enter into another core specialty market
    where there is a high unmet need and significant growth
    potential, to better serve the needs of the urology community
    and its patients, thus increasing the Companys market
    presence and opportunities for growth in sales, earnings and
    stockholder returns.
</td>
</tr>
<tr style="line-height: 6pt; font-size: 1pt"><td></td></tr>
<tr style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF" valign="top">
<td></td>
<td>    
</td>
<td align="left">
<i>Enhanced Product Mix.</i>The acquisition of
    Esprit supports the Companys U.S.growth strategy and
    demonstrates its focus on strengthening the Companys core
    pharmaceutical businesses by creating a dedicated urologics
    division to serve urologists and their patients. The
    complementary nature of Esprits products for overactive
    bladder will enhance the Companys current R&amp;D
    activities in the treatment of urological and genitourinary
    disorders.
</td>
</tr>
</table>
<div style="margin-top: 6pt; font-size: 1pt"></div>
<div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Company believes that these primary factors support the
    amount of goodwill recognized as a result of the purchase price
    paid for Esprit in relation to other acquired tangible and
    intangible assets.
</div>
<div style="margin-top: 12pt; font-size: 1pt"></div>
<div align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">
<b><i><font style="font-family: 'Times New Roman', Times">EndoArt
    Acquisition</font></i></b>
</div>
<div style="margin-top: 6pt; font-size: 1pt"></div>
<div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    On February22, 2007, the Company completed the acquisition
    of EndoArt, a provider of telemetrically-controlled (or
    remote-controlled) implants used in the treatment of morbid
    obesity and other conditions. Under the terms of the purchase
    agreement, the Company acquired all of the outstanding capital
    stock of EndoArt for an aggregate purchase price of
    approximately $97.1million, net of cash acquired. The
    acquisition consideration was all cash, funded from the
    Companys cash and equivalents balances. In connection with
    the EndoArt acquisition, the Company acquired assets with a fair
    value of $98.5million and assumed liabilities of
    $1.4million.
</div>
<div style="margin-top: 6pt; font-size: 1pt"></div>
<div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The following table summarizes the components of the EndoArt
    purchase price:
</div>
<div style="margin-top: 6pt; font-size: 1pt"></div>
<table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF" width="100%">
<!-- Table Width Row BEGIN -->
<tr style="font-size: 1pt" valign="bottom">
<td width="89%"></td> <!-- colindex=01 type=maindata -->
<td width="2%"></td> <!-- colindex=02 type=gutter -->
<td align="right" width="4%"></td> <!-- colindex=02 type=lead -->
<td align="right" width="1%"></td> <!-- colindex=02 type=body -->
<td align="left" width="4%"></td> <!-- colindex=02 type=hang1 -->
</tr>
<!-- Table Width Row END -->
<tr align="center" style="font-size: 8pt" valign="bottom">
<td align="center" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" valign="bottom">
<b>(in millions)</b>
</td>
</tr>
<tr style="line-height: 3pt; font-size: 1pt">
<td>
</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Cash consideration, net of cash acquired
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    96.6
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr valign="bottom">
<td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Transaction costs
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    0.5
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr style="font-size: 1pt" valign="bottom">
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 1px solid #000000">

</td>
<td>

</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    97.1
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr style="font-size: 1pt" valign="bottom">
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 3px double #000000">

</td>
<td>

</td>
</tr>
</table>
<div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
</div>
<div style="margin-top: 12pt; font-size: 1pt"></div>
<div align="left" style="margin-left: 4%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">
<b><i><font style="font-family: 'Times New Roman', Times">Purchase
    Price Allocation</font></i></b>
</div>
<div style="margin-top: 6pt; font-size: 1pt"></div>
<div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The EndoArt purchase price was allocated to tangible and
    intangible assets acquired and liabilities assumed based on
    their estimated fair values at the acquisition date. The excess
    of the purchase price over the fair value of net assets acquired
    was allocated to goodwill. The goodwill acquired in the EndoArt
    acquisition is not deductible for tax purposes.
</div>
<p align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<br/>
    F-16
</p></div><br /><hr noshade=""/><hr noshade=""/><br /><b><i><font style="font-family: 'Times New Roman', Times">EndoArt
    Acquisition</font></i></b><div style="margin-top: 6pt; font-size: 1pt"></div><div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    On February22, 2007, the Company completed the acquisition
    of EndoArt, a provider of telemetrically-controlled (or
    remote-controlled) implants used in the treatment of morbid
    obesity and other conditions. Under the terms of the purchase
    agreement, the Company acquired all of the outstanding capital
    stock of EndoArt for an aggregate purchase price of
    approximately $97.1million, net of cash acquired. The
    acquisition consideration was all cash, funded from the
    Companys cash and equivalents balances. In connection with
    the EndoArt acquisition, the Company acquired assets with a fair
    value of $98.5million and assumed liabilities of
    $1.4million.
</div><div style="margin-top: 6pt; font-size: 1pt"></div><div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The following table summarizes the components of the EndoArt
    purchase price:
</div><div style="margin-top: 6pt; font-size: 1pt"></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF" width="100%">
<!-- Table Width Row BEGIN -->
<tr style="font-size: 1pt" valign="bottom">
<td width="89%"></td> <!-- colindex=01 type=maindata -->
<td width="2%"></td> <!-- colindex=02 type=gutter -->
<td align="right" width="4%"></td> <!-- colindex=02 type=lead -->
<td align="right" width="1%"></td> <!-- colindex=02 type=body -->
<td align="left" width="4%"></td> <!-- colindex=02 type=hang1 -->
</tr>
<!-- Table Width Row END -->
<tr align="center" style="font-size: 8pt" valign="bottom">
<td align="center" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" valign="bottom">
<b>(in millions)</b>
</td>
</tr>
<tr style="line-height: 3pt; font-size: 1pt">
<td>
</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Cash consideration, net of cash acquired
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    96.6
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr valign="bottom">
<td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Transaction costs
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    0.5
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr style="font-size: 1pt" valign="bottom">
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 1px solid #000000">

</td>
<td>

</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    97.1
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr style="font-size: 1pt" valign="bottom">
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 3px double #000000">

</td>
<td>

</td>
</tr>
</table><tr style="font-size: 1pt" valign="bottom">
<td width="89%"></td> <!-- colindex=01 type=maindata -->
<td width="2%"></td> <!-- colindex=02 type=gutter -->
<td align="right" width="4%"></td> <!-- colindex=02 type=lead -->
<td align="right" width="1%"></td> <!-- colindex=02 type=body -->
<td align="left" width="4%"></td> <!-- colindex=02 type=hang1 -->
</tr><td width="89%"></td><tr align="center" style="font-size: 8pt" valign="bottom">
<td align="center" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" valign="bottom">
<b>(in millions)</b>
</td>
</tr><td align="center" nowrap="" valign="bottom">

</td><td align="center" colspan="3" nowrap="" valign="bottom">
<b>(in millions)</b>
</td><b>(in millions)</b><tr style="line-height: 3pt; font-size: 1pt">
<td>
</td>
</tr><td>
</td><tr style="background: #CCEEFF" valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Cash consideration, net of cash acquired
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    96.6
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr><td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Cash consideration, net of cash acquired
</div>
</td><div style="text-indent: -10pt; margin-left: 10pt">
    Cash consideration, net of cash acquired
</div><td>

</td><td align="right" nowrap="" valign="bottom">
    $
</td><td align="right" nowrap="" valign="bottom">
    96.6
</td><td align="left" nowrap="" valign="bottom">

</td><tr valign="bottom">
<td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Transaction costs
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    0.5
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr><td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Transaction costs
</div>
</td><div style="text-indent: -10pt; margin-left: 10pt">
    Transaction costs
</div><td>

</td><td align="right" nowrap="" valign="bottom">
    0.5
</td><td align="left" nowrap="" valign="bottom">

</td><tr style="font-size: 1pt" valign="bottom">
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 1px solid #000000">

</td>
<td>

</td>
</tr><td>

</td><tr style="background: #CCEEFF" valign="bottom">
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    97.1
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr><td align="left" nowrap="" valign="bottom">

</td><td align="right" nowrap="" valign="bottom">
    $
</td><td align="right" nowrap="" valign="bottom">
    97.1
</td><td align="left" nowrap="" valign="bottom">

</td><tr style="font-size: 1pt" valign="bottom">
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 3px double #000000">

</td>
<td>

</td>
</tr><td>

</td><div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
</div><div style="margin-top: 12pt; font-size: 1pt"></div><div align="left" style="margin-left: 4%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">
<b><i><font style="font-family: 'Times New Roman', Times">Purchase
    Price Allocation</font></i></b>
</div><b><i><font style="font-family: 'Times New Roman', Times">Purchase
    Price Allocation</font></i></b><div style="margin-top: 6pt; font-size: 1pt"></div><div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The EndoArt purchase price was allocated to tangible and
    intangible assets acquired and liabilities assumed based on
    their estimated fair values at the acquisition date. The excess
    of the purchase price over the fair value of net assets acquired
    was allocated to goodwill. The goodwill acquired in the EndoArt
    acquisition is not deductible for tax purposes.
</div><p align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<br/>
    F-16
</p><br/><p>
</p><h5 align="left" style="page-break-before:always"><a href="#tocpage">Table of Contents</a></h5><p>
</p><div style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->
<div style="margin-top: 18pt; font-size: 1pt"></div>
<div align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">
<b><font style="font-family: 'Times New Roman', Times">ALLERGAN,
    INC.<br/>
</font></b>
</div>
<div style="margin-top: 6pt; font-size: 1pt"></div>
<div align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">
<b><font style="font-family: 'Times New Roman', Times">NOTESTO
    CONSOLIDATED FINANCIAL
    STATEMENTS(Continued)</font></b>
</div>
<div style="margin-top: 18pt; font-size: 1pt"></div>
<div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Company believes the fair values assigned to the EndoArt
    assets acquired and liabilities assumed were based on reasonable
    assumptions. The following table summarizes the estimated fair
    values of net assets acquired:
</div>
<div style="margin-top: 6pt; font-size: 1pt"></div>
<table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF" width="100%">
<!-- Table Width Row BEGIN -->
<tr style="font-size: 1pt" valign="bottom">
<td width="89%"></td> <!-- colindex=01 type=maindata -->
<td width="2%"></td> <!-- colindex=02 type=gutter -->
<td align="right" width="4%"></td> <!-- colindex=02 type=lead -->
<td align="right" width="1%"></td> <!-- colindex=02 type=body -->
<td align="left" width="4%"></td> <!-- colindex=02 type=hang1 -->
</tr>
<!-- Table Width Row END -->
<tr align="center" style="font-size: 8pt" valign="bottom">
<td align="center" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" valign="bottom">
<b>(in millions)</b>
</td>
</tr>
<tr style="line-height: 3pt; font-size: 1pt">
<td>
</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Current assets
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    0.8
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Property, plant and equipment
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    0.7
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Identifiable intangible assets
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    17.6
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    In-process research and development
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    72.0
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Goodwill
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    7.4
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Accounts payable and accrued liabilities
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    (0.8
</td>
<td align="left" nowrap="" valign="bottom">
    )
</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Deferred tax liabilities
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    (0.6
</td>
<td align="left" nowrap="" valign="bottom">
    )
</td>
</tr>
<tr style="font-size: 1pt" valign="bottom">
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 1px solid #000000">

</td>
<td>

</td>
</tr>
<tr valign="bottom">
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    97.1
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr style="font-size: 1pt" valign="bottom">
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 3px double #000000">

</td>
<td>

</td>
</tr>
</table>
<div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
</div>
<div style="margin-top: 12pt; font-size: 1pt"></div>
<div align="left" style="margin-left: 4%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">
<b><i><font style="font-family: 'Times New Roman', Times">In-process
    Research and Development</font></i></b>
</div>
<div style="margin-top: 6pt; font-size: 1pt"></div>
<div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In conjunction with the EndoArt acquisition, the Company
    recorded an in-process research and development expense of
    $72.0million related to EndoArts
    <i>EasyBand</i><sup style="font-size: 85%; vertical-align: text-top"></sup>
    Remote Adjustable Gastric Band System in the United States,
    which had not received approval by the U.S.Food and Drug
    Administration (FDA) as of the EndoArt acquisition date of
    February22, 2007 and had no alternative future use.
</div>
<div style="margin-top: 6pt; font-size: 1pt"></div>
<div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    As of the EndoArt acquisition date, the
    <i>EasyBand</i><sup style="font-size: 85%; vertical-align: text-top"></sup>
    Remote Adjustable Gastric Band System was expected to be
    approved by the FDA in 2011. Additional R&amp;D expenses needed
    prior to expected FDA approval are expected to range from
    $20million to $25million. This range represents
    managements best estimate as to the additional R&amp;D
    expenses required to obtain FDA approval to market the product
    in the United States. Remaining efforts will be focused on
    completing discussions with the FDA regarding study design and
    performing a future clinical trial to pursue a premarket
    approval in the United States.
</div>
<div style="margin-top: 6pt; font-size: 1pt"></div>
<div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The estimated fair value of the in-process research and
    development assets was determined based on the use of a
    discounted cash flow model using an income approach for the
    acquired technologies. Estimated revenues were probability
    adjusted to take into account the stage of completion and the
    risks surrounding successful development and commercialization.
    The estimated after-tax cash flows were then discounted to a
    present value using a discount rate of 28%. At the time of the
    EndoArt acquisition, material net cash inflows were estimated to
    begin in 2011.
</div>
<div style="margin-top: 6pt; font-size: 1pt"></div>
<div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The major risks and uncertainties associated with the timely and
    successful completion of the acquired in-process projects
    consist of the ability to confirm the safety and efficacy of the
    technology based on the data from clinical trials and obtaining
    necessary regulatory approvals. No assurance can be given that
    the underlying assumptions used to forecast cash flows or the
    timely and successful completion of the projects will
    materialize as estimated. For these reasons, among others,
    actual results may vary significantly from estimated results.
</div>
<p align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<br/>
    F-17
</p></div><br /><hr noshade=""/><hr noshade=""/><br /><b><i><font style="font-family: 'Times New Roman', Times">Cornal
    Acquisition</font></i></b><div style="margin-top: 6pt; font-size: 1pt"></div><div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    On January2, 2007, the Company purchased all of the
    outstanding common stock of Cornal, a privately held
    healthcare company that develops, manufactures and markets
    dermal fillers, viscoelastics and a range of ophthalmic surgical
    device products, for an aggregate purchase price of
    approximately $209.2million, net of $2.3million
    associated with the settlement of a pre-existing unfavorable
    distribution agreement. The Company recorded the
    $2.3million charge at the acquisition date to effectively
    settle a pre-existing unfavorable distribution agreement between
    Cornal and one of the Companys subsidiaries,
    primarily related to distribution rights for
    <i>Juvderm</i><sup style="font-size: 85%; vertical-align: text-top"><font style="font-variant: SMALL-CAPS">tm</font></sup>
    in the United States. Prior to the acquisition, the Company also
    had a $4.4million payable to Cornal outstanding for
</div><i>Juvderm</i><sup style="font-size: 85%; vertical-align: text-top"><font style="font-variant: SMALL-CAPS">tm</font></sup><p align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<br/>
    F-18
</p><br/><p>
</p><h5 align="left" style="page-break-before:always"><a href="#tocpage">Table of Contents</a></h5><p>
</p><div style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->
<div style="margin-top: 18pt; font-size: 1pt"></div>
<div align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">
<b><font style="font-family: 'Times New Roman', Times">ALLERGAN,
    INC.<br/>
</font></b>
</div>
<div style="margin-top: 6pt; font-size: 1pt"></div>
<div align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">
<b><font style="font-family: 'Times New Roman', Times">NOTESTO
    CONSOLIDATED FINANCIAL
    STATEMENTS(Continued)</font></b>
</div>
<div style="margin-top: 18pt; font-size: 1pt"></div>
<div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    products purchased under the distribution agreement, which was
    effectively settled upon the acquisition. In connection with the
    Cornal acquisition, the Company acquired assets with a
    fair value of $284.8million and assumed liabilities of
    $75.6million. As a result of the acquisition, the Company
    obtained the technology, manufacturing process and worldwide
    distribution rights for
    <i>Juvderm</i><sup style="font-size: 85%; vertical-align: text-top"><font style="font-variant: SMALL-CAPS">tm</font></sup>,
    <i>Surgiderm</i><sup style="font-size: 85%; vertical-align: text-top"></sup>
    and certain other hyaluronic acid-based dermal fillers. The
    acquisition was funded from the Companys cash and
    equivalents balances and its committed long-term credit facility.
</div>
<div style="margin-top: 6pt; font-size: 1pt"></div>
<div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The following table summarizes the components of the
    Cornal purchase price:
</div>
<div style="margin-top: 6pt; font-size: 1pt"></div>
<table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF" width="100%">
<!-- Table Width Row BEGIN -->
<tr style="font-size: 1pt" valign="bottom">
<td width="89%"></td> <!-- colindex=01 type=maindata -->
<td width="2%"></td> <!-- colindex=02 type=gutter -->
<td align="right" width="4%"></td> <!-- colindex=02 type=lead -->
<td align="right" width="1%"></td> <!-- colindex=02 type=body -->
<td align="left" width="4%"></td> <!-- colindex=02 type=hang1 -->
</tr>
<!-- Table Width Row END -->
<tr align="center" style="font-size: 8pt" valign="bottom">
<td align="center" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" valign="bottom">
<b>(in millions)</b>
</td>
</tr>
<tr style="line-height: 3pt; font-size: 1pt">
<td>
</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Cash consideration, net of cash acquired
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    212.0
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr valign="bottom">
<td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Transaction costs
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    3.9
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr style="font-size: 1pt" valign="bottom">
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 1px solid #000000">

</td>
<td>

</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Cash paid
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    215.9
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Less relief from a previously existing third-party payable
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    (4.4
</td>
<td align="left" nowrap="" valign="bottom">
    )
</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Less settlement of a pre-existing distribution agreement
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    (2.3
</td>
<td align="left" nowrap="" valign="bottom">
    )
</td>
</tr>
<tr style="font-size: 1pt" valign="bottom">
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 1px solid #000000">

</td>
<td>

</td>
</tr>
<tr valign="bottom">
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    209.2
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr style="font-size: 1pt" valign="bottom">
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 3px double #000000">

</td>
<td>

</td>
</tr>
</table>
<div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
</div>
<div style="margin-top: 12pt; font-size: 1pt"></div>
<div align="left" style="margin-left: 4%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">
<b><i><font style="font-family: 'Times New Roman', Times">Purchase
    Price Allocation</font></i></b>
</div>
<div style="margin-top: 6pt; font-size: 1pt"></div>
<div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Cornal purchase price was allocated to tangible and
    intangible assets acquired and liabilities assumed based upon
    their estimated fair values at the acquisition date. The excess
    of the purchase price over the fair value of net assets acquired
    was allocated to goodwill. The goodwill acquired in the
    Cornal acquisition is not deductible for tax purposes.
</div>
<div style="margin-top: 6pt; font-size: 1pt"></div>
<div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Company believes the fair values assigned to the
    Cornal assets acquired and liabilities assumed were based
    upon reasonable assumptions. The following table summarizes the
    estimated fair values of the net assets acquired:
</div>
<div style="margin-top: 6pt; font-size: 1pt"></div>
<table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF" width="100%">
<!-- Table Width Row BEGIN -->
<tr style="font-size: 1pt" valign="bottom">
<td width="89%"></td> <!-- colindex=01 type=maindata -->
<td width="2%"></td> <!-- colindex=02 type=gutter -->
<td align="right" width="4%"></td> <!-- colindex=02 type=lead -->
<td align="right" width="1%"></td> <!-- colindex=02 type=body -->
<td align="left" width="4%"></td> <!-- colindex=02 type=hang1 -->
</tr>
<!-- Table Width Row END -->
<tr align="center" style="font-size: 8pt" valign="bottom">
<td align="center" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" valign="bottom">
<b>(in millions)</b>
</td>
</tr>
<tr style="line-height: 3pt; font-size: 1pt">
<td>
</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Current assets
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    38.9
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Property, plant and equipment
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    19.5
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Identifiable intangible assets
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    115.7
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr valign="bottom">
<td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Goodwill
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    109.2
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Other non-current assets
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    1.5
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Accounts payable and accrued liabilities
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    (16.4
</td>
<td align="left" nowrap="" valign="bottom">
    )
</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Current portion of long-term debt
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    (11.6
</td>
<td align="left" nowrap="" valign="bottom">
    )
</td>
</tr>
<tr valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Deferred tax liabilities non-current
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    (45.0
</td>
<td align="left" nowrap="" valign="bottom">
    )
</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Other non-current liabilities
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    (2.6
</td>
<td align="left" nowrap="" valign="bottom">
    )
</td>
</tr>
<tr style="font-size: 1pt" valign="bottom">
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 1px solid #000000">

</td>
<td>

</td>
</tr>
<tr valign="bottom">
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    209.2
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr style="font-size: 1pt" valign="bottom">
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 3px double #000000">

</td>
<td>

</td>
</tr>
</table>
<div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
</div>
<div style="margin-top: 12pt; font-size: 1pt"></div>
<div align="left" style="margin-left: 4%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">
<b><i><font style="font-family: 'Times New Roman', Times">In-process
    Research and Development</font></i></b>
</div>
<div style="margin-top: 6pt; font-size: 1pt"></div>
<div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In conjunction with the Cornal acquisition, the Company
    determined that the R&amp;D efforts related to Cornal
    products did not give rise to identifiable in-process research
    and development assets with anticipated future economic value
    that could be reasonably estimated.
</div>
<p align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<br/>
    F-19
</p></div><div style="margin-top: 18pt; font-size: 1pt"></div><div align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">
<b><font style="font-family: 'Times New Roman', Times">ALLERGAN,
    INC.<br/>
</font></b>
</div><b><font style="font-family: 'Times New Roman', Times">ALLERGAN,
    INC.<br/>
</font></b><br/><div style="margin-top: 6pt; font-size: 1pt"></div><div align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">
<b><font style="font-family: 'Times New Roman', Times">NOTESTO
    CONSOLIDATED FINANCIAL
    STATEMENTS(Continued)</font></b>
</div><b><font style="font-family: 'Times New Roman', Times">NOTESTO
    CONSOLIDATED FINANCIAL
    STATEMENTS(Continued)</font></b><div style="margin-top: 18pt; font-size: 1pt"></div><div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    products purchased under the distribution agreement, which was
    effectively settled upon the acquisition. In connection with the
    Cornal acquisition, the Company acquired assets with a
    fair value of $284.8million and assumed liabilities of
    $75.6million. As a result of the acquisition, the Company
    obtained the technology, manufacturing process and worldwide
    distribution rights for
    <i>Juvderm</i><sup style="font-size: 85%; vertical-align: text-top"><font style="font-variant: SMALL-CAPS">tm</font></sup>,
    <i>Surgiderm</i><sup style="font-size: 85%; vertical-align: text-top"></sup>
    and certain other hyaluronic acid-based dermal fillers. The
    acquisition was funded from the Companys cash and
    equivalents balances and its committed long-term credit facility.
</div><i>Juvderm</i><sup style="font-size: 85%; vertical-align: text-top"><font style="font-variant: SMALL-CAPS">tm</font></sup><i>Surgiderm</i><sup style="font-size: 85%; vertical-align: text-top"></sup><div style="margin-top: 6pt; font-size: 1pt"></div><div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The following table summarizes the components of the
    Cornal purchase price:
</div><div style="margin-top: 6pt; font-size: 1pt"></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF" width="100%">
<!-- Table Width Row BEGIN -->
<tr style="font-size: 1pt" valign="bottom">
<td width="89%"></td> <!-- colindex=01 type=maindata -->
<td width="2%"></td> <!-- colindex=02 type=gutter -->
<td align="right" width="4%"></td> <!-- colindex=02 type=lead -->
<td align="right" width="1%"></td> <!-- colindex=02 type=body -->
<td align="left" width="4%"></td> <!-- colindex=02 type=hang1 -->
</tr>
<!-- Table Width Row END -->
<tr align="center" style="font-size: 8pt" valign="bottom">
<td align="center" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" valign="bottom">
<b>(in millions)</b>
</td>
</tr>
<tr style="line-height: 3pt; font-size: 1pt">
<td>
</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Cash consideration, net of cash acquired
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    212.0
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr valign="bottom">
<td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Transaction costs
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    3.9
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr style="font-size: 1pt" valign="bottom">
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 1px solid #000000">

</td>
<td>

</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Cash paid
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    215.9
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Less relief from a previously existing third-party payable
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    (4.4
</td>
<td align="left" nowrap="" valign="bottom">
    )
</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Less settlement of a pre-existing distribution agreement
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    (2.3
</td>
<td align="left" nowrap="" valign="bottom">
    )
</td>
</tr>
<tr style="font-size: 1pt" valign="bottom">
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 1px solid #000000">

</td>
<td>

</td>
</tr>
<tr valign="bottom">
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    209.2
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr style="font-size: 1pt" valign="bottom">
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 3px double #000000">

</td>
<td>

</td>
</tr>
</table><tr style="font-size: 1pt" valign="bottom">
<td width="89%"></td> <!-- colindex=01 type=maindata -->
<td width="2%"></td> <!-- colindex=02 type=gutter -->
<td align="right" width="4%"></td> <!-- colindex=02 type=lead -->
<td align="right" width="1%"></td> <!-- colindex=02 type=body -->
<td align="left" width="4%"></td> <!-- colindex=02 type=hang1 -->
</tr><td width="89%"></td><tr align="center" style="font-size: 8pt" valign="bottom">
<td align="center" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" valign="bottom">
<b>(in millions)</b>
</td>
</tr><td align="center" nowrap="" valign="bottom">

</td><td align="center" colspan="3" nowrap="" valign="bottom">
<b>(in millions)</b>
</td><b>(in millions)</b><tr style="line-height: 3pt; font-size: 1pt">
<td>
</td>
</tr><td>
</td><tr style="background: #CCEEFF" valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Cash consideration, net of cash acquired
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    212.0
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr><td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Cash consideration, net of cash acquired
</div>
</td><div style="text-indent: -10pt; margin-left: 10pt">
    Cash consideration, net of cash acquired
</div><td>

</td><td align="right" nowrap="" valign="bottom">
    $
</td><td align="right" nowrap="" valign="bottom">
    212.0
</td><td align="left" nowrap="" valign="bottom">

</td><tr valign="bottom">
<td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Transaction costs
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    3.9
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr><td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Transaction costs
</div>
</td><div style="text-indent: -10pt; margin-left: 10pt">
    Transaction costs
</div><td>

</td><td align="right" nowrap="" valign="bottom">
    3.9
</td><td align="left" nowrap="" valign="bottom">

</td><tr style="font-size: 1pt" valign="bottom">
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 1px solid #000000">

</td>
<td>

</td>
</tr><td>

</td><tr style="background: #CCEEFF" valign="bottom">
<td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Cash paid
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    215.9
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr><td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Cash paid
</div>
</td><div style="text-indent: -10pt; margin-left: 10pt">
    Cash paid
</div><td>

</td><td align="right" nowrap="" valign="bottom">
    215.9
</td><td align="left" nowrap="" valign="bottom">

</td><tr valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Less relief from a previously existing third-party payable
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    (4.4
</td>
<td align="left" nowrap="" valign="bottom">
    )
</td>
</tr><td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Less relief from a previously existing third-party payable
</div>
</td><div style="text-indent: -10pt; margin-left: 10pt">
    Less relief from a previously existing third-party payable
</div><td>

</td><td align="right" nowrap="" valign="bottom">
    (4.4
</td><td align="left" nowrap="" valign="bottom">
    )
</td><tr style="background: #CCEEFF" valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Less settlement of a pre-existing distribution agreement
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    (2.3
</td>
<td align="left" nowrap="" valign="bottom">
    )
</td>
</tr><td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Less settlement of a pre-existing distribution agreement
</div>
</td><div style="text-indent: -10pt; margin-left: 10pt">
    Less settlement of a pre-existing distribution agreement
</div><td>

</td><td align="right" nowrap="" valign="bottom">
    (2.3
</td><td align="left" nowrap="" valign="bottom">
    )
</td><tr style="font-size: 1pt" valign="bottom">
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 1px solid #000000">

</td>
<td>

</td>
</tr><td>

</td><tr valign="bottom">
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    209.2
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr><td align="left" nowrap="" valign="bottom">

</td><td align="right" nowrap="" valign="bottom">
    $
</td><td align="right" nowrap="" valign="bottom">
    209.2
</td><td align="left" nowrap="" valign="bottom">

</td><tr style="font-size: 1pt" valign="bottom">
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 3px double #000000">

</td>
<td>

</td>
</tr><td>

</td><div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
</div><div style="margin-top: 12pt; font-size: 1pt"></div><div align="left" style="margin-left: 4%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">
<b><i><font style="font-family: 'Times New Roman', Times">Purchase
    Price Allocation</font></i></b>
</div><b><i><font style="font-family: 'Times New Roman', Times">Purchase
    Price Allocation</font></i></b><div style="margin-top: 6pt; font-size: 1pt"></div><div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Cornal purchase price was allocated to tangible and
    intangible assets acquired and liabilities assumed based upon
    their estimated fair values at the acquisition date. The excess
    of the purchase price over the fair value of net assets acquired
    was allocated to goodwill. The goodwill acquired in the
    Cornal acquisition is not deductible for tax purposes.
</div><div style="margin-top: 6pt; font-size: 1pt"></div><div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Company believes the fair values assigned to the
    Cornal assets acquired and liabilities assumed were based
    upon reasonable assumptions. The following table summarizes the
    estimated fair values of the net assets acquired:
</div><div style="margin-top: 6pt; font-size: 1pt"></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF" width="100%">
<!-- Table Width Row BEGIN -->
<tr style="font-size: 1pt" valign="bottom">
<td width="89%"></td> <!-- colindex=01 type=maindata -->
<td width="2%"></td> <!-- colindex=02 type=gutter -->
<td align="right" width="4%"></td> <!-- colindex=02 type=lead -->
<td align="right" width="1%"></td> <!-- colindex=02 type=body -->
<td align="left" width="4%"></td> <!-- colindex=02 type=hang1 -->
</tr>
<!-- Table Width Row END -->
<tr align="center" style="font-size: 8pt" valign="bottom">
<td align="center" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" valign="bottom">
<b>(in millions)</b>
</td>
</tr>
<tr style="line-height: 3pt; font-size: 1pt">
<td>
</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Current assets
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    38.9
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Property, plant and equipment
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    19.5
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Identifiable intangible assets
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    115.7
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr valign="bottom">
<td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Goodwill
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    109.2
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Other non-current assets
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    1.5
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Accounts payable and accrued liabilities
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    (16.4
</td>
<td align="left" nowrap="" valign="bottom">
    )
</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Current portion of long-term debt
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    (11.6
</td>
<td align="left" nowrap="" valign="bottom">
    )
</td>
</tr>
<tr valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Deferred tax liabilities non-current
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    (45.0
</td>
<td align="left" nowrap="" valign="bottom">
    )
</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Other non-current liabilities
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    (2.6
</td>
<td align="left" nowrap="" valign="bottom">
    )
</td>
</tr>
<tr style="font-size: 1pt" valign="bottom">
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 1px solid #000000">

</td>
<td>

</td>
</tr>
<tr valign="bottom">
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    209.2
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr style="font-size: 1pt" valign="bottom">
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 3px double #000000">

</td>
<td>

</td>
</tr>
</table><tr style="font-size: 1pt" valign="bottom">
<td width="89%"></td> <!-- colindex=01 type=maindata -->
<td width="2%"></td> <!-- colindex=02 type=gutter -->
<td align="right" width="4%"></td> <!-- colindex=02 type=lead -->
<td align="right" width="1%"></td> <!-- colindex=02 type=body -->
<td align="left" width="4%"></td> <!-- colindex=02 type=hang1 -->
</tr><td width="89%"></td><tr align="center" style="font-size: 8pt" valign="bottom">
<td align="center" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" valign="bottom">
<b>(in millions)</b>
</td>
</tr><td align="center" nowrap="" valign="bottom">

</td><td align="center" colspan="3" nowrap="" valign="bottom">
<b>(in millions)</b>
</td><b>(in millions)</b><tr style="line-height: 3pt; font-size: 1pt">
<td>
</td>
</tr><td>
</td><tr style="background: #CCEEFF" valign="bottom">
<td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Current assets
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    38.9
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr><td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Current assets
</div>
</td><div style="text-indent: -10pt; margin-left: 10pt">
    Current assets
</div><td>

</td><td align="right" nowrap="" valign="bottom">
    $
</td><td align="right" nowrap="" valign="bottom">
    38.9
</td><td align="left" nowrap="" valign="bottom">

</td><tr valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Property, plant and equipment
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    19.5
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr><td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Property, plant and equipment
</div>
</td><div style="text-indent: -10pt; margin-left: 10pt">
    Property, plant and equipment
</div><td>

</td><td align="right" nowrap="" valign="bottom">
    19.5
</td><td align="left" nowrap="" valign="bottom">

</td><tr style="background: #CCEEFF" valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Identifiable intangible assets
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    115.7
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr><td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Identifiable intangible assets
</div>
</td><div style="text-indent: -10pt; margin-left: 10pt">
    Identifiable intangible assets
</div><td>

</td><td align="right" nowrap="" valign="bottom">
    115.7
</td><td align="left" nowrap="" valign="bottom">

</td><tr valign="bottom">
<td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Goodwill
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    109.2
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr><td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Goodwill
</div>
</td><div style="text-indent: -10pt; margin-left: 10pt">
    Goodwill
</div><td>

</td><td align="right" nowrap="" valign="bottom">
    109.2
</td><td align="left" nowrap="" valign="bottom">

</td><tr style="background: #CCEEFF" valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Other non-current assets
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    1.5
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr><td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Other non-current assets
</div>
</td><div style="text-indent: -10pt; margin-left: 10pt">
    Other non-current assets
</div><td>

</td><td align="right" nowrap="" valign="bottom">
    1.5
</td><td align="left" nowrap="" valign="bottom">

</td><tr valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Accounts payable and accrued liabilities
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    (16.4
</td>
<td align="left" nowrap="" valign="bottom">
    )
</td>
</tr><td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Accounts payable and accrued liabilities
</div>
</td><div style="text-indent: -10pt; margin-left: 10pt">
    Accounts payable and accrued liabilities
</div><td>

</td><td align="right" nowrap="" valign="bottom">
    (16.4
</td><td align="left" nowrap="" valign="bottom">
    )
</td><tr style="background: #CCEEFF" valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Current portion of long-term debt
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    (11.6
</td>
<td align="left" nowrap="" valign="bottom">
    )
</td>
</tr><td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Current portion of long-term debt
</div>
</td><div style="text-indent: -10pt; margin-left: 10pt">
    Current portion of long-term debt
</div><td>

</td><td align="right" nowrap="" valign="bottom">
    (11.6
</td><td align="left" nowrap="" valign="bottom">
    )
</td><tr valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Deferred tax liabilities non-current
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    (45.0
</td>
<td align="left" nowrap="" valign="bottom">
    )
</td>
</tr><td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Deferred tax liabilities non-current
</div>
</td><div style="text-indent: -10pt; margin-left: 10pt">
    Deferred tax liabilities non-current
</div><td>

</td><td align="right" nowrap="" valign="bottom">
    (45.0
</td><td align="left" nowrap="" valign="bottom">
    )
</td><tr style="background: #CCEEFF" valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Other non-current liabilities
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    (2.6
</td>
<td align="left" nowrap="" valign="bottom">
    )
</td>
</tr><td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Other non-current liabilities
</div>
</td><div style="text-indent: -10pt; margin-left: 10pt">
    Other non-current liabilities
</div><td>

</td><td align="right" nowrap="" valign="bottom">
    (2.6
</td><td align="left" nowrap="" valign="bottom">
    )
</td><tr style="font-size: 1pt" valign="bottom">
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 1px solid #000000">

</td>
<td>

</td>
</tr><td>

</td><tr valign="bottom">
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    209.2
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr><td align="left" nowrap="" valign="bottom">

</td><td align="right" nowrap="" valign="bottom">
    $
</td><td align="right" nowrap="" valign="bottom">
    209.2
</td><td align="left" nowrap="" valign="bottom">

</td><tr style="font-size: 1pt" valign="bottom">
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 3px double #000000">

</td>
<td>

</td>
</tr><td>

</td><div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
</div><div style="margin-top: 12pt; font-size: 1pt"></div><div align="left" style="margin-left: 4%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">
<b><i><font style="font-family: 'Times New Roman', Times">In-process
    Research and Development</font></i></b>
</div><b><i><font style="font-family: 'Times New Roman', Times">In-process
    Research and Development</font></i></b><div style="margin-top: 6pt; font-size: 1pt"></div><div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In conjunction with the Cornal acquisition, the Company
    determined that the R&amp;D efforts related to Cornal
    products did not give rise to identifiable in-process research
    and development assets with anticipated future economic value
    that could be reasonably estimated.
</div><p align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<br/>
    F-19
</p><br/><p>
</p><h5 align="left" style="page-break-before:always"><a href="#tocpage">Table of Contents</a></h5><p>
</p><div style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->
<div style="margin-top: 18pt; font-size: 1pt"></div>
<div align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">
<b><font style="font-family: 'Times New Roman', Times">ALLERGAN,
    INC.<br/>
</font></b>
</div>
<div style="margin-top: 6pt; font-size: 1pt"></div>
<div align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">
<b><font style="font-family: 'Times New Roman', Times">NOTESTO
    CONSOLIDATED FINANCIAL
    STATEMENTS(Continued)</font></b>
</div>
<div style="margin-top: 18pt; font-size: 1pt"></div>
<div align="left" style="margin-left: 4%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">
<b><i><font style="font-family: 'Times New Roman', Times">Identifiable
    Intangible Assets</font></i></b>
</div>
<div style="margin-top: 6pt; font-size: 1pt"></div>
<div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Acquired identified intangible assets include product rights for
    approved indications of currently marketed products, core
    technology and trademarks. The amount assigned to each class of
    intangible assets and the related weighted-average amortization
    periods are summarized in the following table:
</div>
<div style="margin-top: 6pt; font-size: 1pt"></div>
<table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF" width="100%">
<!-- Table Width Row BEGIN -->
<tr style="font-size: 1pt" valign="bottom">
<td width="65%"></td> <!-- colindex=01 type=maindata -->
<td width="2%"></td> <!-- colindex=02 type=gutter -->
<td align="right" width="6%"></td> <!-- colindex=02 type=lead -->
<td align="right" width="1%"></td> <!-- colindex=02 type=body -->
<td align="left" width="6%"></td> <!-- colindex=02 type=hang1 -->
<td width="3%"></td> <!-- colindex=03 type=gutter -->
<td align="right" width="8%"></td> <!-- colindex=03 type=lead -->
<td align="right" width="1%"></td> <!-- colindex=03 type=body -->
<td align="left" width="8%"></td> <!-- colindex=03 type=hang1 -->
</tr>
<!-- Table Width Row END -->
<tr align="center" style="font-size: 8pt" valign="bottom">
<td align="center" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" valign="bottom">
<b>Value of<br/>
</b>
</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" valign="bottom">

</td>
</tr>
<tr align="center" style="font-size: 8pt" valign="bottom">
<td align="center" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" valign="bottom">
<b>Intangible Assets<br/>
</b>
</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" valign="bottom">
<b>Weighted Average<br/>
</b>
</td>
</tr>
<tr align="center" style="font-size: 8pt" valign="bottom">
<td align="center" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" style="border-bottom: 1px solid #000000" valign="bottom">
<b>Acquired</b>
</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" style="border-bottom: 1px solid #000000" valign="bottom">
<b>Amortization Period</b>
</td>
</tr>
<tr align="center" style="font-size: 8pt" valign="bottom">
<td align="center" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" valign="bottom">
<b>(in millions)</b>
</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" valign="bottom">

</td>
</tr>
<tr style="line-height: 3pt; font-size: 1pt">
<td>
</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Developed technology
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    72.4
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    8.3years
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr valign="bottom">
<td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Core technology
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    39.4
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    13.0years
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Trademarks
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    3.9
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    9.5years
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr style="font-size: 1pt" valign="bottom">
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 1px solid #000000">

</td>
<td>

</td>
<td>

</td>
<td>

</td>
<td>

</td>
<td>

</td>
</tr>
<tr valign="bottom">
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    115.7
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr style="font-size: 1pt" valign="bottom">
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 3px double #000000">

</td>
<td>

</td>
<td>

</td>
<td>

</td>
<td>

</td>
<td>

</td>
</tr>
</table>
<div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
</div>
<div style="margin-top: 6pt; font-size: 1pt"></div>
<div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Acquired developed technology assets primarily consist of the
    following currently marketed Cornal products:
</div>
<div style="margin-top: 6pt; font-size: 1pt"></div>
<table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF" width="100%">
<!-- Table Width Row BEGIN -->
<tr style="font-size: 1pt" valign="bottom">
<td width="85%"></td> <!-- colindex=01 type=maindata -->
<td width="2%"></td> <!-- colindex=02 type=gutter -->
<td align="right" width="6%"></td> <!-- colindex=02 type=lead -->
<td align="right" width="1%"></td> <!-- colindex=02 type=body -->
<td align="left" width="6%"></td> <!-- colindex=02 type=hang1 -->
</tr>
<!-- Table Width Row END -->
<tr align="center" style="font-size: 8pt" valign="bottom">
<td align="center" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" valign="bottom">
<b>Value of<br/>
</b>
</td>
</tr>
<tr align="center" style="font-size: 8pt" valign="bottom">
<td align="center" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" valign="bottom">
<b>Intangible Assets<br/>
</b>
</td>
</tr>
<tr align="center" style="font-size: 8pt" valign="bottom">
<td align="center" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" style="border-bottom: 1px solid #000000" valign="bottom">
<b>Acquired</b>
</td>
</tr>
<tr align="center" style="font-size: 8pt" valign="bottom">
<td align="center" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" valign="bottom">
<b>(in millions)</b>
</td>
</tr>
<tr style="line-height: 3pt; font-size: 1pt">
<td>
</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt"><i>Juvderm</i><font style="font-variant: SMALL-CAPS"><sup style="font-size: 85%; vertical-align: text-top">tm</sup></font>
worldwide</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    56.1
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr valign="bottom">
<td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
<i>Surgiderm</i><sup style="font-size: 85%; vertical-align: text-top"></sup>
    worldwide
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    13.1
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Other
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">

</td>
<td align="right" nowrap="" valign="bottom">
    3.2
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr style="font-size: 1pt" valign="bottom">
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 1px solid #000000">

</td>
<td>

</td>
</tr>
<tr valign="bottom">
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    72.4
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr style="font-size: 1pt" valign="bottom">
<td>

</td>
<td>

</td>
<td>

</td>
<td style="border-top: 3px double #000000">

</td>
<td>

</td>
</tr>
</table>
<div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
</div>
<div style="margin-top: 6pt; font-size: 1pt"></div>
<div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Impairment evaluations in the future for acquired developed
    technology will occur at a consolidated cash flow level within
    the Companys medical devices segment, with valuation
    analysis and related potential impairment actions segregated
    among the United States, the European Union, Canada, Australia
    and the rest of the world, which were the markets used to
    originally value the intangible assets.
</div>
<div style="margin-top: 6pt; font-size: 1pt"></div>
<div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The Company determined that the Cornal assets acquired
    included proprietary technology which has alternative future use
    in the development of aesthetics products. These assets were
    separately valued and capitalized as core technology. Trademarks
    acquired are primarily related to
    <i>Juvderm</i><sup style="font-size: 85%; vertical-align: text-top"><font style="font-variant: SMALL-CAPS">tm</font></sup>
    and
    <i>Surgiderm</i><sup style="font-size: 85%; vertical-align: text-top"></sup>.
</div>
<div style="margin-top: 12pt; font-size: 1pt"></div>
<div align="left" style="margin-left: 4%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">
<b><i><font style="font-family: 'Times New Roman', Times">Goodwill</font></i></b>
</div>
<div style="margin-top: 6pt; font-size: 1pt"></div>
<div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Goodwill represents the excess of the Cornal purchase
    price over the sum of the amounts assigned to assets acquired
    less liabilities assumed. The Company believes that the
    Cornal acquisition will produce the following significant
    benefits:
</div>
<div style="margin-top: 6pt; font-size: 1pt"></div>
<table border="0" cellpadding="0" cellspacing="0" width="100%">
<tr>
<td width="4%"></td>
<td width="2%"></td>
<td width="94%"></td>
</tr>
<tr style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF" valign="top">
<td></td>
<td>    
</td>
<td align="left">
<i>Control over the Manufacturing Process and Future Research
    and Development.</i>The acquisition will allow the
    Company to control product quality and availability and to gain
    additional expertise and intellectual property to further
    develop the next generation of dermal fillers.
</td>
</tr>
<tr style="line-height: 6pt; font-size: 1pt"><td></td></tr>
<tr style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF" valign="top">
<td></td>
<td>    
</td>
<td align="left">
<i>Expanded Distribution Rights.</i>The Company has
    expanded its exclusive distribution rights for
    <i>Juvderm</i><sup style="font-size: 85%; vertical-align: text-top"><font style="font-variant: SMALL-CAPS">tm</font></sup>
    from the United States, Canada and Australia to all countries
    worldwide.
</td>
</tr>
<tr style="line-height: 6pt; font-size: 1pt"><td></td></tr>
<tr style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF" valign="top">
<td></td>
<td>    
</td>
<td align="left">
<i>Enhanced Product Mix.</i>The complementary nature
    of the Companys facial aesthetics products with those of
    Cornal should benefit current and future customers of both
    companies.
</td>
</tr>
<tr style="line-height: 6pt; font-size: 1pt"><td></td></tr>
<tr style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF" valign="top">
<td></td>
<td>    
</td>
<td align="left">
<i>Operating Efficiencies.</i>The combination of the
    Company and Cornal provides the opportunity for product
    cost savings due to manufacturing efficiencies.
</td>
</tr>
</table>
<p align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<br/>
    F-20
</p></div><br /><hr noshade=""/><hr noshade=""/><br /><b><i><font style="font-family: 'Times New Roman', Times">Inamed
    Acquisition</font></i></b><div style="margin-top: 6pt; font-size: 1pt"></div><div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    On March23, 2006, the Company completed the acquisition of
    Inamed, a global healthcare company that develops, manufactures
    and markets a diverse line of products, including breast
    implants, a range of facial aesthetics and obesity intervention
    products, for approximately $3.3billion, consisting of
    approximately $1.4billion in cash and
    34,883,386shares of the Companys common stock with a
    fair value of approximately $1.9billion. In connection
    with the acquisition, the Company acquired assets with a fair
    value of $3,813.4million and assumed liabilities of
    $522.7million.
</div><div style="margin-top: 6pt; font-size: 1pt"></div><div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In connection with the Inamed acquisition, the Company recorded
    a total charge to in-process research and development expense of
    $579.3million in 2006 for acquired in-process research and
    development assets that the Company determined were not yet
    complete and had no alternative future uses in their current
    state. The Company recorded a $562.8million expense for
    in-process research and development during the first fiscal
    quarter of 2006 and an additional charge of $16.5million
    during the second fiscal quarter of 2006. The acquired
    in-process research and development assets are composed of
    Inameds silicone breast implant technology for use in the
    United States, Inameds
    <i>Juvderm</i><sup style="font-size: 85%; vertical-align: text-top"><font style="font-variant: SMALL-CAPS">tm</font></sup>
    dermal filler technology for use in the United States, and
    Inameds
    <i>BIB</i><sup style="font-size: 85%; vertical-align: text-top"><font style="font-variant: SMALL-CAPS">tm</font></sup><i>
    BioEnterics</i><sup style="font-size: 85%; vertical-align: text-top"></sup>
    Intragastric Balloon technology for use in the United States,
    which were valued at $405.8million, $41.2million and
    $132.3million, respectively. All of these assets had not
    received approval by the FDA as of the Inamed acquisition date
    of March23, 2006. Because the in-process research and
    development assets had no alternative future use, they were
    charged to expense on the Inamed acquisition date.
</div><i>Juvderm</i><sup style="font-size: 85%; vertical-align: text-top"><font style="font-variant: SMALL-CAPS">tm</font></sup><i>BIB</i><sup style="font-size: 85%; vertical-align: text-top"><font style="font-variant: SMALL-CAPS">tm</font></sup><i>
    BioEnterics</i><sup style="font-size: 85%; vertical-align: text-top"></sup><div style="margin-top: 12pt; font-size: 1pt"></div><div align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">
<b><i><font style="font-family: 'Times New Roman', Times">Pro
    Forma Results of Operations</font></i></b>
</div><b><i><font style="font-family: 'Times New Roman', Times">Pro
    Forma Results of Operations</font></i></b><div style="margin-top: 6pt; font-size: 1pt"></div><div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The following unaudited <i>pro forma </i>operating results for
    the year ended December31, 2007 assume the Esprit
    acquisition had occurred on January1, 2007, and for the
    year ended December31, 2006, assume the Esprit and Inamed
    acquisitions had occurred on January1, 2006, and exclude
    any <i>pro forma </i>charges for in-process research and
    development, inventory fair value adjustments, share-based
    compensation expense and transaction costs.
</div><i>pro forma </i><div style="margin-top: 6pt; font-size: 1pt"></div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF" width="100%">
<!-- Table Width Row BEGIN -->
<tr style="font-size: 1pt" valign="bottom">
<td width="81%"></td> <!-- colindex=01 type=maindata -->
<td width="2%"></td> <!-- colindex=02 type=gutter -->
<td align="right" width="3%"></td> <!-- colindex=02 type=lead -->
<td align="right" width="1%"></td> <!-- colindex=02 type=body -->
<td align="left" width="3%"></td> <!-- colindex=02 type=hang1 -->
<td width="3%"></td> <!-- colindex=03 type=gutter -->
<td align="right" width="3%"></td> <!-- colindex=03 type=lead -->
<td align="right" width="1%"></td> <!-- colindex=03 type=body -->
<td align="left" width="3%"></td> <!-- colindex=03 type=hang1 -->
</tr>
<!-- Table Width Row END -->
<tr align="center" style="font-size: 8pt" valign="bottom">
<td align="center" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" style="border-bottom: 1px solid #000000" valign="bottom">
<b>2007</b>
</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" style="border-bottom: 1px solid #000000" valign="bottom">
<b>2006</b>
</td>
</tr>
<tr align="center" style="font-size: 8pt" valign="bottom">
<td align="center" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="7" valign="bottom">
<b>(in millions, except per share amounts)</b>
</td>
</tr>
<tr style="line-height: 3pt; font-size: 1pt">
<td>
</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Product net sales
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    3,911.9
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    3,147.1
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr valign="bottom">
<td align="left" nowrap="" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Total revenues
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    3,971.8
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    3,200.3
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Net earnings from continuing operations
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    461.5
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    411.3
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Net earnings per share from continuing operations
    basic
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    1.51
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    1.36
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
<tr style="background: #CCEEFF" valign="bottom">
<td align="left" valign="bottom">
<div style="text-indent: -10pt; margin-left: 10pt">
    Net earnings per share from continuing operations
    diluted
</div>
</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    1.49
</td>
<td align="left" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="right" nowrap="" valign="bottom">
    $
</td>
<td align="right" nowrap="" valign="bottom">
    1.34
</td>
<td align="left" nowrap="" valign="bottom">

</td>
</tr>
</table><tr style="font-size: 1pt" valign="bottom">
<td width="81%"></td> <!-- colindex=01 type=maindata -->
<td width="2%"></td> <!-- colindex=02 type=gutter -->
<td align="right" width="3%"></td> <!-- colindex=02 type=lead -->
<td align="right" width="1%"></td> <!-- colindex=02 type=body -->
<td align="left" width="3%"></td> <!-- colindex=02 type=hang1 -->
<td width="3%"></td> <!-- colindex=03 type=gutter -->
<td align="right" width="3%"></td> <!-- colindex=03 type=lead -->
<td align="right" width="1%"></td> <!-- colindex=03 type=body -->
<td align="left" width="3%"></td> <!-- colindex=03 type=hang1 -->
</tr><td width="81%"></td><tr align="center" style="font-size: 8pt" valign="bottom">
<td align="center" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" style="border-bottom: 1px solid #000000" valign="bottom">
<b>2007</b>
</td>
<td>

</td>
<td align="center" colspan="3" nowrap="" style="border-bottom: 1px solid #000000" valign="bottom">
<b>2006</b>
</td>
</tr><td align="center" nowrap="" valign="bottom">

</td><td align="center" colspan="3" nowrap="" style="border-bottom: 1px solid #000000" valign="bottom">
<b>2007</b>
</td><b>2007</b><td>

</td><td align="center" colspan="3" nowrap="" style="border-bottom: 1px solid #000000" valign="bottom">
<b>2006</b>
</td><b>2006</b><tr align="center" style="font-size: 8pt" valign="bottom">
<td align="center" nowrap="" valign="bottom">

</td>
<td>

</td>
<td align="center" colspan="7" valign="bottom">
<b>(in millions, except per share amounts)</b>
</td>
</tr>